US20020048596A1
(en)
*
|
1994-12-30 |
2002-04-25 |
Gregor Cevc |
Preparation for the transport of an active substance across barriers
|
DE69633222T2
(de)
*
|
1995-02-24 |
2005-09-08 |
Elan Pharma International Ltd. |
Nanopartikel-dispersionen enthaltende aerosole
|
US6479526B1
(en)
|
1995-04-12 |
2002-11-12 |
The Procter & Gamble Company |
Pharmaceutical composition for inhibiting the growth of viruses and cancers
|
US6727280B2
(en)
|
1997-01-07 |
2004-04-27 |
Sonus Pharmaceuticals, Inc. |
Method for treating colorectal carcinoma using a taxane/tocopherol formulation
|
US6506783B1
(en)
|
1997-05-16 |
2003-01-14 |
The Procter & Gamble Company |
Cancer treatments and pharmaceutical compositions therefor
|
IS4518A
(is)
*
|
1997-07-09 |
1999-01-10 |
Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group |
Nýtt lyfjaform fyrir bóluefni
|
US6087350A
(en)
|
1997-08-29 |
2000-07-11 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
|
US7135191B2
(en)
*
|
1997-09-04 |
2006-11-14 |
Zsolt Istvan Hertelendy |
Urogenital or anorectal transmucosal vaccine delivery system
|
US6974590B2
(en)
*
|
1998-03-27 |
2005-12-13 |
Cima Labs Inc. |
Sublingual buccal effervescent
|
US20030091629A1
(en)
*
|
1998-03-27 |
2003-05-15 |
Cima Labs Inc. |
Sublingual buccal effervescent
|
US20120046237A1
(en)
*
|
1998-04-08 |
2012-02-23 |
Theoharides Theoharis C |
Compositions for protection against superficial vasodilator flush syndrome, and methods of use
|
US7030155B2
(en)
|
1998-06-05 |
2006-04-18 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
JP2002523475A
(ja)
*
|
1998-09-02 |
2002-07-30 |
アラーガン・セイルズ・インコーポレイテッド |
防腐したシクロデキストリン含有組成物
|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
RU2207844C2
(ru)
|
1998-12-23 |
2003-07-10 |
Идеа Аг. |
УСОВЕРШЕНСТВОВАННЫЙ ПРЕПАРАТ ДЛЯ МЕСТНОГО НЕИНВАЗИВНОГО ПРИМЕНЕНИЯ in vivo
|
SI1031347T1
(en)
|
1999-01-27 |
2002-10-31 |
Idea Ag |
Transnasal transport/immunisation with highly adaptable carriers
|
SI1031346T1
(en)
|
1999-01-27 |
2002-08-31 |
Idea Ag |
Noninvasive vaccination through the skin
|
US6294192B1
(en)
*
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
US20030104048A1
(en)
*
|
1999-02-26 |
2003-06-05 |
Lipocine, Inc. |
Pharmaceutical dosage forms for highly hydrophilic materials
|
TR200102778T2
(tr)
*
|
1999-03-11 |
2002-05-21 |
Fujisawa Pharmaceutical Co. Ltd. |
Lipozom preparatları
|
EG23951A
(en)
*
|
1999-03-25 |
2008-01-29 |
Otsuka Pharma Co Ltd |
Cilostazol preparation
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
US6982281B1
(en)
*
|
2000-11-17 |
2006-01-03 |
Lipocine Inc |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
AU5409699A
(en)
*
|
1999-07-05 |
2001-01-22 |
Idea Ag |
A method for the improvement of transport across adaptable semi-permeable barriers
|
US6747058B1
(en)
*
|
1999-08-20 |
2004-06-08 |
Unimed Pharmaceuticals, Inc. |
Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor
|
US7648696B2
(en)
*
|
1999-08-20 |
2010-01-19 |
Unimed Pharmaceuticals, Llc |
Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent
|
BRPI0014470B1
(pt)
*
|
1999-10-08 |
2016-08-23 |
Affinium Pharm Inc |
compostos inibidores de fab i, composição farmacêutica, processo de preparação dos compostos e uso dos compostos para a produção de medicamento para tratamento de infecções bacterianas
|
US6720001B2
(en)
*
|
1999-10-18 |
2004-04-13 |
Lipocine, Inc. |
Emulsion compositions for polyfunctional active ingredients
|
US7364752B1
(en)
|
1999-11-12 |
2008-04-29 |
Abbott Laboratories |
Solid dispersion pharamaceutical formulations
|
CA2359945C
(en)
*
|
1999-11-12 |
2011-04-26 |
Abbott Laboratories |
Inhibitors of crystallization in a solid dispersion
|
US6524623B1
(en)
*
|
1999-11-12 |
2003-02-25 |
Milton Hodosh |
Therapeutic compositions and methods of use thereof
|
US20030180352A1
(en)
*
|
1999-11-23 |
2003-09-25 |
Patel Mahesh V. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US20010036479A1
(en)
*
|
2000-01-14 |
2001-11-01 |
Gillian Cave |
Glyburide composition
|
SE0000773D0
(sv)
*
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
New formulation
|
AU6381201A
(en)
*
|
2000-03-28 |
2001-10-08 |
Biochemie Gmbh |
Granulated particles with masked taste
|
FR2807662A1
(fr)
*
|
2000-04-12 |
2001-10-19 |
Cll Pharma |
Procede pour stabiliser la granulometrie d'un principe actif verulent disperse dans un liquide et ses applications
|
AU2001251650A1
(en)
*
|
2000-04-18 |
2001-10-30 |
Pharmacia Corporation |
Rapid-onset formulation of a selective cyclooxigenase-2
|
SG98393A1
(en)
|
2000-05-19 |
2003-09-19 |
Inst Materials Research & Eng |
Injectable drug delivery systems with cyclodextrin-polymer based hydrogels
|
DE10026698A1
(de)
*
|
2000-05-30 |
2001-12-06 |
Basf Ag |
Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
|
US6596306B1
(en)
*
|
2000-07-07 |
2003-07-22 |
David Ho Sue San Ho |
Drug delivery system:formulation for fat-soluble drugs
|
US7007861B2
(en)
*
|
2000-06-08 |
2006-03-07 |
S.C. Johnson & Son, Inc. |
Methods and personal protection devices for repelling insects
|
US6623765B1
(en)
*
|
2000-08-01 |
2003-09-23 |
University Of Florida, Research Foundation, Incorporated |
Microemulsion and micelle systems for solubilizing drugs
|
US6531158B1
(en)
*
|
2000-08-09 |
2003-03-11 |
Impax Laboratories, Inc. |
Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
US7276249B2
(en)
*
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US20080241070A1
(en)
*
|
2000-09-21 |
2008-10-02 |
Elan Pharma International Ltd. |
Fenofibrate dosage forms
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
DE60104206T2
(de)
|
2000-09-22 |
2005-09-22 |
Galephar M/F |
Halbfeste arzneizubereitung enthaltend isotretinoin
|
US6380232B1
(en)
|
2000-09-26 |
2002-04-30 |
The Procter & Gamble Company |
Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
|
WO2002026324A2
(en)
*
|
2000-09-27 |
2002-04-04 |
Sonus Pharmaceuticals, Inc. |
Tocol-based compositions containing amiodarone
|
AU2001293177A1
(en)
*
|
2000-09-27 |
2002-04-08 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
AU2001296908A1
(en)
*
|
2000-09-29 |
2002-04-08 |
Geneva Pharmaceuticals, Inc. |
Proton pump inhibitor formulation
|
US6919378B2
(en)
*
|
2000-10-11 |
2005-07-19 |
Cephalon, Inc. |
Pharmaceutical solutions of modafinil compounds
|
WO2002058689A1
(en)
*
|
2000-12-05 |
2002-08-01 |
Childrens Hospital Los Angeles |
Pharmaceutical compositions of fenretinide having increased bioavailability and methods of using the same
|
US8449908B2
(en)
*
|
2000-12-22 |
2013-05-28 |
Alltranz, Llc |
Transdermal delivery of cannabidiol
|
US8067032B2
(en)
*
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
FR2818905A1
(fr)
*
|
2000-12-28 |
2002-07-05 |
Cll Pharma |
Compositions pharmaceutiques colloidales micellaires renfermant un principe actif lipophile
|
AU2002231970B2
(en)
*
|
2001-02-14 |
2007-08-16 |
GW Research Limited |
Mucoadhesive pharmaceutical formulations
|
GB0105772D0
(en)
*
|
2001-03-08 |
2001-04-25 |
Sterix Ltd |
Use
|
EP1560584B1
(de)
*
|
2001-04-06 |
2009-01-14 |
Affinium Pharmaceuticals, Inc. |
Fab-i-inhibitoren
|
AUPR510001A0
(en)
*
|
2001-05-18 |
2001-06-14 |
Jupitar Pty Ltd |
Formulation and method
|
EP1392262A1
(de)
*
|
2001-05-24 |
2004-03-03 |
Alexza Molecular Delivery Corporation |
Verabreichung von arzneimittel-estern durch inhalation
|
KR100911779B1
(ko)
*
|
2001-05-25 |
2009-08-12 |
세파론, 인코포레이티드 |
모다피닐을 포함하는 고형 제약 제제
|
US20080058424A1
(en)
*
|
2002-05-23 |
2008-03-06 |
Cephalon, Inc. |
Novel pharmaceutical formulations of modafinil
|
EP1404345A2
(de)
*
|
2001-05-31 |
2004-04-07 |
Pharmacia Corporation |
Hautpermeable selektive cyclooxygenase-2 inhibitor-zusammensetzung
|
JP2003063965A
(ja)
*
|
2001-06-13 |
2003-03-05 |
Otsuka Pharmaceut Factory Inc |
注射用シロスタゾール水性製剤
|
GB0114532D0
(en)
*
|
2001-06-14 |
2001-08-08 |
Jagotec Ag |
Novel compositions
|
US7244703B2
(en)
*
|
2001-06-22 |
2007-07-17 |
Bentley Pharmaceuticals, Inc. |
Pharmaceutical compositions and methods for peptide treatment
|
US7758890B2
(en)
|
2001-06-23 |
2010-07-20 |
Lyotropic Therapeutics, Inc. |
Treatment using dantrolene
|
US20030045587A1
(en)
*
|
2001-06-23 |
2003-03-06 |
David Anderson |
Solvent system
|
US8741378B1
(en)
|
2001-06-27 |
2014-06-03 |
Advanced Cardiovascular Systems, Inc. |
Methods of coating an implantable device
|
AU2002325192B2
(en)
|
2001-07-06 |
2008-05-22 |
Veloxis Pharmaceuticals, Inc. |
Controlled agglomeration
|
US7033604B2
(en)
|
2001-07-06 |
2006-04-25 |
Sucampo Ag |
Composition for topical administration
|
GB0118300D0
(en)
*
|
2001-07-26 |
2001-09-19 |
Cortendo Ab |
Formulations
|
FR2827770B1
(fr)
*
|
2001-07-27 |
2005-08-19 |
Gattefosse Ets Sa |
Composition pharmaceutique a usage oral comprenant un principe actif susceptible de subir un important effet de premier passage intestinal
|
AU2002333194B2
(en)
*
|
2001-08-16 |
2006-05-04 |
Lyfjathroun H.F., Biopharmaceuticals |
A method of producing antibodies ex-vivo
|
SE0102855D0
(sv)
*
|
2001-08-27 |
2001-08-27 |
Astrazeneca Ab |
Method of treatment
|
GB0121580D0
(en)
*
|
2001-09-06 |
2001-10-24 |
Syngenta Ltd |
Novel compounds
|
US6878693B2
(en)
*
|
2001-09-28 |
2005-04-12 |
Solubest Ltd. |
Hydrophilic complexes of lipophilic materials and an apparatus and method for their production
|
US20050249786A1
(en)
*
|
2001-09-28 |
2005-11-10 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
|
US20050227911A1
(en)
*
|
2001-09-28 |
2005-10-13 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
|
US20050233003A1
(en)
*
|
2001-09-28 |
2005-10-20 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of salicylic acid
|
US20050191359A1
(en)
*
|
2001-09-28 |
2005-09-01 |
Solubest Ltd. |
Water soluble nanoparticles and method for their production
|
AR036852A1
(es)
*
|
2001-10-19 |
2004-10-06 |
Isotechnika Inc |
Preconcentrado de una microemulsion de analogos de ciclosporina, su metodo de preparacion y metodos para producir inmunosupresion
|
US20050049291A1
(en)
*
|
2001-10-23 |
2005-03-03 |
Mukesh Kumar |
Process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2-enzyme inhibitors
|
TWI312285B
(en)
*
|
2001-10-25 |
2009-07-21 |
Depomed Inc |
Methods of treatment using a gastric retained gabapentin dosage
|
US7612112B2
(en)
|
2001-10-25 |
2009-11-03 |
Depomed, Inc. |
Methods of treatment using a gastric retained gabapentin dosage
|
WO2003035063A1
(en)
*
|
2001-10-25 |
2003-05-01 |
Dinesh Shantilal Patel |
Novel preparation of selective cyclooxygenase ii inhibitors
|
US20060159743A1
(en)
*
|
2001-10-25 |
2006-07-20 |
Depomed, Inc. |
Methods of treating non-nociceptive pain states with gastric retentive gabapentin
|
US20030203930A1
(en)
*
|
2001-10-26 |
2003-10-30 |
Imtiaz Chaudry |
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
|
US20030191151A1
(en)
*
|
2001-10-26 |
2003-10-09 |
Imtiaz Chaudry |
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
|
US6702997B2
(en)
|
2001-10-26 |
2004-03-09 |
Dey, L.P. |
Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
|
US20030140920A1
(en)
*
|
2001-10-26 |
2003-07-31 |
Dey L.P. |
Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
|
JP2003221335A
(ja)
|
2001-10-26 |
2003-08-05 |
Dey Lp |
慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
|
JP2005514346A
(ja)
*
|
2001-11-09 |
2005-05-19 |
キュー エル ティー インク. |
光感作剤及び皮膚浸透エンハンサーを含有する組成物並びに光力学療法におけるそれらの使用
|
US7264629B2
(en)
*
|
2001-11-09 |
2007-09-04 |
Qlt, Inc. |
Photodynamic therapy for the treatment of hair loss
|
US7700851B2
(en)
*
|
2001-11-13 |
2010-04-20 |
U.S. Smokeless Tobacco Company |
Tobacco nicotine demethylase genomic clone and uses thereof
|
WO2003045357A1
(en)
*
|
2001-11-27 |
2003-06-05 |
Transform Pharmaceuticals, Inc. |
Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
|
DE10159120B4
(de)
*
|
2001-12-01 |
2006-08-17 |
Lts Lohmann Therapie-Systeme Ag |
Steroidhormonhaltige transdermale therapeutische Systeme enthaltend Propylenglycolmonocaprylat und seine Verwendung
|
CA2469119A1
(en)
*
|
2001-12-03 |
2003-06-12 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin d compounds
|
CA2471241A1
(en)
*
|
2001-12-20 |
2003-07-03 |
Bernard Charles Sherman |
Pharmaceutical compositions comprising a cyclosporin, a hydrophilic surfactant and a lipophilic surfactant
|
US20030139386A1
(en)
*
|
2001-12-21 |
2003-07-24 |
Sophie Cote |
Pharmaceutical compositions based on azetidine derivatives
|
CA2470524A1
(en)
*
|
2001-12-21 |
2003-07-24 |
David S. Soane |
Use of oligomers and polymers for drug solublization, stabilization, and delivery
|
KR100441167B1
(ko)
*
|
2001-12-27 |
2004-07-21 |
씨제이 주식회사 |
마이크로에멀젼 예비 농축액 조성물
|
US20030129253A1
(en)
*
|
2002-01-03 |
2003-07-10 |
Milley Christopher J. |
Stable aqueous suspension
|
US20030129242A1
(en)
*
|
2002-01-04 |
2003-07-10 |
Bosch H. William |
Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
|
US20030165566A1
(en)
*
|
2002-01-10 |
2003-09-04 |
O'toole Edel |
Sedative non-benzodiazepine formulations
|
ES2305434T3
(es)
|
2002-02-01 |
2008-11-01 |
Pfizer Products Inc. |
Composiciones framaceuticas de dispersiones amorfas de farmacos y materiales que forman microfases lipofilas.
|
RU2004123621A
(ru)
*
|
2002-02-01 |
2005-04-10 |
Пфайзер Продактс Инк. (Us) |
Лекарственные формы с немедленным высвобождением, содержащие твердые дисперсии лекарств
|
EP1920766B1
(de)
|
2002-02-01 |
2017-08-23 |
Bend Research, Inc |
Pharmazeutische Zusammensetzungen amorpher Dispersionen von Wirkstoffen und lipophiler mikrophasenbildender Materialien
|
US20100311701A1
(en)
*
|
2002-02-15 |
2010-12-09 |
Transform Pharmaceuticals, Inc |
Pharmaceutical Co-Crystal Compositions
|
US7790905B2
(en)
|
2002-02-15 |
2010-09-07 |
Mcneil-Ppc, Inc. |
Pharmaceutical propylene glycol solvate compositions
|
US20090088443A1
(en)
*
|
2002-02-15 |
2009-04-02 |
Julius Remenar |
Novel crystalline forms of conazoles and methods of making and using the same
|
US7927613B2
(en)
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
CN1610559A
(zh)
*
|
2002-02-15 |
2005-04-27 |
奈克斯麦德控股有限公司 |
用于治疗勃起障碍的前列腺组合物
|
WO2003070280A2
(en)
*
|
2002-02-25 |
2003-08-28 |
Lyfjathroun Hf |
Absorption enhancing agent
|
DE60313956T2
(de)
*
|
2002-02-26 |
2008-05-15 |
Astrazeneca Ab |
Pharmazeutische iressa zusammensetzung enthaltend ein wasserlösliches cellulosederivat
|
IL163846A0
(en)
|
2002-03-01 |
2005-12-18 |
Univ South Florida |
Multiple-component solid phases containing at least one active pharmaceutical ingredient
|
ES2283756T3
(es)
*
|
2002-03-01 |
2007-11-01 |
Novagali Pharma Sa |
Sistemas autoemulsionantes de administracion de farmaco para taxoides.
|
US6623780B1
(en)
|
2002-03-26 |
2003-09-23 |
Cargill, Inc. |
Aqueous dispersible sterol product
|
US20040005351A1
(en)
*
|
2002-03-29 |
2004-01-08 |
Kwon Glen S. |
Polymeric micelle formulations of hydrophobic compounds and methods
|
AUPS158502A0
(en)
*
|
2002-04-08 |
2002-05-16 |
Dermcare-Vet Pty Ltd |
Allergic dermatitis composition and method of treatment
|
JP4599604B2
(ja)
*
|
2002-04-19 |
2010-12-15 |
カーギル テクスチュアライジング ソリューションズ ドイチュラント ゲゼルシャフト ミット ベシュレクテル ハフツング ウント コンパニー コマンディートゲゼルシャフト |
生体活性のリン脂質含有成分を含有するマトリックス
|
US6869939B2
(en)
|
2002-05-04 |
2005-03-22 |
Cydex, Inc. |
Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
|
US20050215552A1
(en)
*
|
2002-05-17 |
2005-09-29 |
Gadde Kishore M |
Method for treating obesity
|
TW200402289A
(en)
*
|
2002-05-17 |
2004-02-16 |
Wyeth Corp |
Methods of treating gastrointestinary and genitourinary pain disorders
|
US20030225031A1
(en)
*
|
2002-05-21 |
2003-12-04 |
Quay Steven C. |
Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid
|
WO2003097026A1
(fr)
*
|
2002-05-22 |
2003-11-27 |
Nihon Pharmaceutical Co., Ltd. |
Inhibiteur du peristaltisme de muscles lisses
|
US7229644B2
(en)
*
|
2002-05-23 |
2007-06-12 |
Cephalon, Inc. |
Pharmaceutical formulations of modafinil
|
GB0211949D0
(en)
*
|
2002-05-23 |
2002-07-03 |
Glaxo Group Ltd |
Novel compounds compositions and processes
|
WO2003099773A1
(en)
|
2002-05-24 |
2003-12-04 |
Millennium Pharmaceuticals, Inc. |
Ccr9 inhibitors and methods of use thereof
|
US20070264348A1
(en)
*
|
2002-05-24 |
2007-11-15 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US20040018237A1
(en)
*
|
2002-05-31 |
2004-01-29 |
Perricone Nicholas V. |
Topical drug delivery using phosphatidylcholine
|
US20070059356A1
(en)
*
|
2002-05-31 |
2007-03-15 |
Almarsson Oern |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
WO2003101445A1
(en)
*
|
2002-06-03 |
2003-12-11 |
Activbiotics, Inc. |
Intravenous rifalazil formulation and methods of use thereof
|
US20030228363A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Patel Mahendra R. |
Stabilized pharmaceutical compositons containing benzimidazole compounds
|
JP2005531606A
(ja)
*
|
2002-06-10 |
2005-10-20 |
エラン ファーマ インターナショナル,リミティド |
ナノ粒子ステロール製剤およびステロールの組合せ
|
US7842693B2
(en)
|
2002-06-12 |
2010-11-30 |
Chemocentryx, Inc. |
Substituted piperazines
|
US7589199B2
(en)
|
2002-06-12 |
2009-09-15 |
Chemocentryx, Inc. |
Substituted piperazines
|
US7306819B2
(en)
|
2002-06-12 |
2007-12-11 |
The Coca-Cola Company |
Beverages containing plant sterols
|
CN100563466C
(zh)
|
2002-06-12 |
2009-12-02 |
可口可乐公司 |
含有植物甾醇的饮料
|
US20030232097A1
(en)
*
|
2002-06-17 |
2003-12-18 |
Strides Inc. |
Oily wax matrix suspension formulation comprising ibuprofen free acid and potassium salt of ibuprofen
|
EP1515703A1
(de)
*
|
2002-06-21 |
2005-03-23 |
Transform Pharmaceuticals, Inc. |
Pharmazeutische zusammensetzungen mit verbesserter auflösung
|
ITMI20021392A1
(it)
*
|
2002-06-25 |
2003-12-29 |
Nicox Sa |
Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
US6855332B2
(en)
*
|
2002-07-03 |
2005-02-15 |
Lyfjathroun Hf. |
Absorption promoting agent
|
US8840928B2
(en)
|
2002-07-05 |
2014-09-23 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
US10004729B2
(en)
|
2002-07-05 |
2018-06-26 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
US8557291B2
(en)
|
2002-07-05 |
2013-10-15 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent pharmaceutical compositions of opioids and other drugs
|
US7399488B2
(en)
|
2002-07-05 |
2008-07-15 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent pharmaceutical compositions of opiods and other drugs
|
WO2004006921A1
(ja)
*
|
2002-07-11 |
2004-01-22 |
Takeda Pharmaceutical Company Limited |
被覆製剤の製造法
|
CN100519643C
(zh)
|
2002-07-19 |
2009-07-29 |
奥默罗斯公司 |
可生物降解的三嵌段共聚物,它们的合成方法和从它制得的水凝胶和生物材料
|
US7608252B2
(en)
*
|
2002-07-19 |
2009-10-27 |
The Gillette Company |
Shave gel composition containing polyglyceryl ester surfactant
|
KR100533458B1
(ko)
*
|
2002-07-20 |
2005-12-07 |
대화제약 주식회사 |
파클리탁셀의 가용화용 조성물 및 그의 제조 방법
|
KR100573289B1
(ko)
*
|
2002-07-20 |
2006-04-24 |
대화제약 주식회사 |
방광내 투여를 통한 방광암치료용 파클리탁셀 조성물 및그의 제조 방법
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
EP1534238A1
(de)
*
|
2002-07-29 |
2005-06-01 |
ALZA Corporation |
Formulierungen und dosierformen fuer die kontrollierte abgabe von topiramat
|
GB2391471B
(en)
*
|
2002-08-02 |
2005-05-04 |
Satishchandra Punambhai Patel |
Pharmaceutical compositions
|
AU2002950744A0
(en)
*
|
2002-08-13 |
2002-09-12 |
Medihoney Pty Ltd |
Composition
|
US7445796B2
(en)
*
|
2002-08-19 |
2008-11-04 |
L. Perrigo Company |
Pharmaceutically active particles of a monomodal particle size distribution and method
|
US20040116532A1
(en)
*
|
2002-09-13 |
2004-06-17 |
Craig Heacock |
Pharmaceutical formulations of modafinil
|
US20040058895A1
(en)
*
|
2002-09-18 |
2004-03-25 |
Bone Care International, Inc. |
Multi-use vessels for vitamin D formulations
|
US20040053895A1
(en)
*
|
2002-09-18 |
2004-03-18 |
Bone Care International, Inc. |
Multi-use vessels for vitamin D formulations
|
US7148211B2
(en)
*
|
2002-09-18 |
2006-12-12 |
Genzyme Corporation |
Formulation for lipophilic agents
|
DE10244847A1
(de)
*
|
2002-09-20 |
2004-04-01 |
Ulrich Prof. Dr. Speck |
Medizinische Vorrichtung zur Arzneimittelabgabe
|
AU2003267231A1
(en)
*
|
2002-09-20 |
2004-04-08 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical compositions with improved dissolution
|
EP1832583A1
(de)
|
2002-09-30 |
2007-09-12 |
A/S GEA Farmaceutisk Fabrik |
Neue Schwefelsäureadditionssalze aus Raloxifen und/oder Solvate daraus sowie pharmazeutische Zusammensetzungen damit
|
US20040105778A1
(en)
*
|
2002-10-04 |
2004-06-03 |
Elan Pharma International Limited |
Gamma irradiation of solid nanoparticulate active agents
|
US20040105881A1
(en)
*
|
2002-10-11 |
2004-06-03 |
Gregor Cevc |
Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
|
WO2004037212A2
(en)
*
|
2002-10-24 |
2004-05-06 |
Sepracor, Inc. |
Compositions comprising zopiclone derivatives and methods of making and using the same
|
KR100508518B1
(ko)
*
|
2002-11-13 |
2005-08-17 |
한미약품 주식회사 |
초임계유체 공정을 이용한 파클리탁셀 고체분산체의 제조방법 및 이 방법으로 제조된 파클리탁셀 고체분산체
|
US7741519B2
(en)
*
|
2007-04-23 |
2010-06-22 |
Chemocentryx, Inc. |
Bis-aryl sulfonamides
|
US7227035B2
(en)
*
|
2002-11-18 |
2007-06-05 |
Chemocentryx |
Bis-aryl sulfonamides
|
US20070021466A1
(en)
*
|
2002-11-18 |
2007-01-25 |
Solomon Ungashe |
CCR2 inhibitors and methods of use thereof
|
US7420055B2
(en)
*
|
2002-11-18 |
2008-09-02 |
Chemocentryx, Inc. |
Aryl sulfonamides
|
KR100866456B1
(ko)
|
2002-11-18 |
2008-10-31 |
케모센트릭스 |
아릴 술폰아마이드
|
IS6633A
(is)
*
|
2002-11-22 |
2004-05-23 |
Omega Farma Ehf. |
Samsetningar af fínasteríð töflum
|
US20060148877A1
(en)
*
|
2002-11-26 |
2006-07-06 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical formulations of celcoxib
|
US20040110828A1
(en)
*
|
2002-11-27 |
2004-06-10 |
Chowdhury Dipak K. |
Tetrahydrocannabinol compositions and methods of manufacture and use thereof
|
US20080188392A1
(en)
*
|
2002-12-02 |
2008-08-07 |
Diamond Chemical Company, Inc. |
Laundry Compositions
|
US7368418B2
(en)
*
|
2002-12-02 |
2008-05-06 |
Diamond Chemical Company, Inc. |
Laundry compositions
|
DK1575951T3
(da)
*
|
2002-12-06 |
2014-09-15 |
Debiopharm Int Sa |
Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
|
US20040115226A1
(en)
*
|
2002-12-12 |
2004-06-17 |
Wenji Li |
Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same
|
JP2006511525A
(ja)
*
|
2002-12-13 |
2006-04-06 |
ヤゴテック アーゲー |
ナノ粒子状スピロノラクトン局所製剤
|
US6979672B2
(en)
*
|
2002-12-20 |
2005-12-27 |
Polichem, S.A. |
Cyclosporin-based pharmaceutical compositions
|
US8183290B2
(en)
|
2002-12-30 |
2012-05-22 |
Mcneil-Ppc, Inc. |
Pharmaceutically acceptable propylene glycol solvate of naproxen
|
KR100767097B1
(ko)
*
|
2002-12-31 |
2007-10-15 |
니콜라스 브이. 페리콘 |
안정한 국부적인 약물 전달 조성물
|
US20040131672A1
(en)
*
|
2003-01-07 |
2004-07-08 |
Nilobon Podhipleux |
Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
|
JP4567945B2
(ja)
*
|
2003-01-17 |
2010-10-27 |
太陽化学株式会社 |
ユビデカレノン製剤
|
EP1596872B1
(de)
*
|
2003-01-24 |
2011-06-22 |
Flora Technology Inc. |
Zusammensetzungen und verfahren zur wiederherstellung der bakterienflora
|
US20040186155A1
(en)
*
|
2003-01-30 |
2004-09-23 |
Dayno Jeffrey Marc |
Combination therapy for the treatment or prevention of migraine
|
US20050220870A1
(en)
*
|
2003-02-20 |
2005-10-06 |
Bonnie Hepburn |
Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
|
CA2517005A1
(en)
*
|
2003-02-20 |
2004-09-02 |
Santarus, Inc. |
A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
|
TWI323660B
(en)
*
|
2003-02-25 |
2010-04-21 |
Otsuka Pharma Co Ltd |
Pten inhibitor or maxi-k channels opener
|
CA2516667C
(en)
*
|
2003-03-04 |
2012-05-29 |
Lyotropic Therapeutics, Inc. |
Treatment using dantrolene
|
EP1608377B1
(de)
|
2003-03-17 |
2008-10-01 |
Affinium Pharmaceuticals, Inc. |
Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend
|
TW200501939A
(en)
*
|
2003-03-18 |
2005-01-16 |
Hisamitsu Pharmaceutical Co |
Patch containing nonsteroidal anti-inflammatory and analgesic agent
|
US20040185009A1
(en)
*
|
2003-03-19 |
2004-09-23 |
Dexcel Pharma Technologies Ltd. |
Composition and device for treating periodontal diseases
|
ES2496102T3
(es)
*
|
2003-03-28 |
2014-09-18 |
Sigmoid Pharma Limited |
Forma de dosificación oral sólida que contiene microcápsulas sin fisuras
|
US20040191207A1
(en)
*
|
2003-03-31 |
2004-09-30 |
Lipari John M. |
Alpha-hydroxy acid ester drug delivery compositions and methods of use
|
JP4931128B2
(ja)
|
2003-04-10 |
2012-05-16 |
ニューロジェシックス, インコーポレイテッド |
Trpv1アゴニストの投与のための方法および組成物
|
EP1617909A1
(de)
*
|
2003-04-23 |
2006-01-25 |
QLT Inc. |
Haarwachstum
|
MXPA05011557A
(es)
|
2003-04-29 |
2006-03-09 |
Orexigen Therapeutics Inc |
Composiciones para afectar perdida de peso.
|
US20070099996A1
(en)
*
|
2003-05-20 |
2007-05-03 |
Shashikanth Isloor |
Pharmaceutical compositions of acitretin
|
JP2007501683A
(ja)
*
|
2003-05-22 |
2007-02-01 |
エラン ファーマ インターナショナル リミテッド |
γ線照射によるナノ粒子活性物質分散体の滅菌法
|
US20040258754A1
(en)
*
|
2003-06-18 |
2004-12-23 |
Valery Alakhov |
Compositions for oral administration of camptothecin and its analogs
|
US20070065463A1
(en)
*
|
2003-06-20 |
2007-03-22 |
Ronald Aung-Din |
Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
|
WO2005000269A1
(en)
*
|
2003-06-26 |
2005-01-06 |
Cipla Limited |
Pharmaceutical formulations comprising a proton pump inhibitor
|
KR100581169B1
(ko)
*
|
2003-07-07 |
2006-05-17 |
한국유나이티드제약 주식회사 |
용해도가 개선된 테르비나핀의 약제조성물 및 그 제조방법
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US20050037070A1
(en)
*
|
2003-07-18 |
2005-02-17 |
Santarus, Inc. |
Pharmaceutical formulatins useful for inhibiting acid secretion and methods for making and using them
|
WO2005007117A2
(en)
*
|
2003-07-18 |
2005-01-27 |
Santarus, Inc. |
Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
|
GB0317663D0
(en)
*
|
2003-07-29 |
2003-09-03 |
Astrazeneca Ab |
Pharmaceutical composition
|
WO2005011635A2
(en)
|
2003-08-04 |
2005-02-10 |
Pfizer Products Inc. |
Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials
|
WO2005016306A2
(en)
*
|
2003-08-06 |
2005-02-24 |
Alza Corporation |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
NZ545145A
(en)
*
|
2003-08-06 |
2009-07-31 |
Nirmal Mulye |
Pharmaceutical composition containing water soluble drug
|
JP2007503389A
(ja)
*
|
2003-08-22 |
2007-02-22 |
アルザ・コーポレーシヨン |
長期間にわたるトピラメートの段階的送達
|
JP4926707B2
(ja)
|
2003-08-22 |
2012-05-09 |
ダニスコ エイ/エス |
封入化抗菌材料
|
GB2388581A
(en)
*
|
2003-08-22 |
2003-11-19 |
Danisco |
Coated aqueous beads
|
US8377952B2
(en)
|
2003-08-28 |
2013-02-19 |
Abbott Laboratories |
Solid pharmaceutical dosage formulation
|
US8025899B2
(en)
|
2003-08-28 |
2011-09-27 |
Abbott Laboratories |
Solid pharmaceutical dosage form
|
WO2005020959A2
(en)
*
|
2003-09-02 |
2005-03-10 |
Alza Corporation |
Novel drug compositions and dosage forms of topiramate
|
US20050059583A1
(en)
|
2003-09-15 |
2005-03-17 |
Allergan, Inc. |
Methods of providing therapeutic effects using cyclosporin components
|
CA2538078C
(en)
*
|
2003-09-25 |
2012-12-04 |
Activbiotics, Inc. |
Rifalazil formulations
|
GB0322552D0
(en)
|
2003-09-26 |
2003-10-29 |
Astrazeneca Uk Ltd |
Therapeutic treatment
|
TR200301614A2
(tr)
*
|
2003-09-26 |
2005-10-21 |
Bi̇ofarma İlaç Sanayi̇ Ve Ti̇caret A.Ş. |
Atorvastatin kalsiyum tablet formülasyonunun hazırlanması için yeni yöntem
|
US7658944B2
(en)
|
2003-10-10 |
2010-02-09 |
Lifecycle Pharma A/S |
Solid dosage form comprising a fibrate
|
KR20060085682A
(ko)
*
|
2003-10-10 |
2006-07-27 |
라이프사이클 파마 에이/에스 |
피브레이트 및 스타틴을 함유하는 고형 제제
|
US9173847B2
(en)
|
2003-10-10 |
2015-11-03 |
Veloxis Pharmaceuticals A/S |
Tablet comprising a fibrate
|
GB0324574D0
(en)
*
|
2003-10-21 |
2003-11-26 |
Glaxo Group Ltd |
Novel compositions
|
US20050096311A1
(en)
*
|
2003-10-30 |
2005-05-05 |
Cns Response |
Compositions and methods for treatment of nervous system disorders
|
US20050096365A1
(en)
*
|
2003-11-03 |
2005-05-05 |
David Fikstad |
Pharmaceutical compositions with synchronized solubilizer release
|
US20070292498A1
(en)
*
|
2003-11-05 |
2007-12-20 |
Warren Hall |
Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
|
US8784869B2
(en)
|
2003-11-11 |
2014-07-22 |
Mattern Pharma Ag |
Controlled release delivery system for nasal applications and methods of treatment
|
DE60303854T2
(de)
|
2003-11-11 |
2006-08-10 |
Mattern, Udo |
Nasenformulierung mit kontrollierter Freisetzung von Sexualhormonen
|
WO2005046651A1
(en)
*
|
2003-11-12 |
2005-05-26 |
Ranbaxy Laboratories Limited |
Liquid filled capsules of doxycycline
|
US7470435B2
(en)
*
|
2003-11-17 |
2008-12-30 |
Andrx Pharmaceuticals, Llc |
Extended release venlafaxine formulation
|
CZ300438B6
(cs)
*
|
2003-11-25 |
2009-05-20 |
Pliva Hrvatska D.O.O. |
Zpusob prípravy orální pevné lékové formy s okamžitým uvolnováním úcinné látky obsahující jako úcinnou látku polymorfní formu finasteridu
|
US7201920B2
(en)
|
2003-11-26 |
2007-04-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of opioid containing dosage forms
|
ES2348303T3
(es)
*
|
2003-12-08 |
2010-12-02 |
Cpex Pharmaceuticals, Inc. |
Composiciones farmacauticas y procedimientos de tratamiento con insulina.
|
JP2007516259A
(ja)
*
|
2003-12-09 |
2007-06-21 |
メッドクリスタルフォームズ、エルエルシー |
活性剤との混合相共結晶の調製方法
|
PE20050596A1
(es)
*
|
2003-12-19 |
2005-10-18 |
Novartis Ag |
Microemulsion que comprende un inhibidor renina
|
KR20060123493A
(ko)
*
|
2003-12-23 |
2006-12-01 |
알자 코포레이션 |
제어된 전달을 위한 약물 조성물의 용해도를 증가시키는방법 및 제형
|
MXPA06007510A
(es)
*
|
2003-12-29 |
2009-06-10 |
Johnson & Johnson |
Composiciones de farmaco y formas de dosis novedosas de topiramato.
|
MXPA06007509A
(es)
*
|
2003-12-29 |
2007-10-18 |
Johnson & Johnson |
Composiciones de farmaco y formas de dosis novedosas.
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
DE602004031462D1
(de)
*
|
2003-12-31 |
2011-03-31 |
Cima Labs Inc |
Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung
|
CA2552611A1
(en)
*
|
2004-01-09 |
2005-08-04 |
Wyeth |
Microemulsions for pharmaceutical compositions
|
GB0400804D0
(en)
|
2004-01-14 |
2004-02-18 |
Innoscience Technology Bv |
Pharmaceutical compositions
|
EP1718303A4
(de)
*
|
2004-02-10 |
2010-09-01 |
Santarus Inc |
Kombination eines protonenpumpenhemmers, puffermittels und einem nichtsteroidalen entzündungshemmenden mittel
|
JP2005255677A
(ja)
*
|
2004-02-12 |
2005-09-22 |
Nof Corp |
シクロスポリン製剤
|
US7084247B2
(en)
*
|
2004-03-11 |
2006-08-01 |
Peptimmune, Inc. |
Identification of self and non-self antigens implicated in autoimmune diseases
|
US20050202079A1
(en)
*
|
2004-03-15 |
2005-09-15 |
Mylan Pharmaceuticals Inc. |
Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
|
US20050202051A1
(en)
*
|
2004-03-15 |
2005-09-15 |
Chinea Vanessa I. |
Pharmaceutical vehicle
|
US7468428B2
(en)
*
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
US20060116336A1
(en)
*
|
2004-03-17 |
2006-06-01 |
American Pharmaceutical Partners, Inc. |
Lyophilized azithromycin formulation
|
US7989490B2
(en)
|
2004-06-02 |
2011-08-02 |
Cordis Corporation |
Injectable formulations of taxanes for cad treatment
|
US8003122B2
(en)
*
|
2004-03-31 |
2011-08-23 |
Cordis Corporation |
Device for local and/or regional delivery employing liquid formulations of therapeutic agents
|
US20050234018A1
(en)
*
|
2004-04-15 |
2005-10-20 |
Allergan, Inc. |
Drug delivery to the back of the eye
|
EP1742630A4
(de)
*
|
2004-04-16 |
2010-01-20 |
Santarus Inc |
Kombination aus protonenpumpenhemmer, puffermittel und prokinetischem wirkstoff
|
US20050238675A1
(en)
*
|
2004-04-26 |
2005-10-27 |
Wenjie Li |
Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications
|
CN1980574A
(zh)
*
|
2004-05-06 |
2007-06-13 |
锡德克斯公司 |
包含舍曲林和磺基烷基醚环糊精的掩味的制剂
|
ES2660172T3
(es)
*
|
2004-05-19 |
2018-03-21 |
Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center |
Composición inyectable que comprende desoxicolato de sodio
|
US7754230B2
(en)
*
|
2004-05-19 |
2010-07-13 |
The Regents Of The University Of California |
Methods and related compositions for reduction of fat
|
US20060127468A1
(en)
*
|
2004-05-19 |
2006-06-15 |
Kolodney Michael S |
Methods and related compositions for reduction of fat and skin tightening
|
AU2005247410A1
(en)
*
|
2004-05-20 |
2005-12-08 |
Discovery Laboratories, Inc. |
Methods , systems and devices for noninvasive pulmonary delivery
|
US8815916B2
(en)
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
EP1750862B1
(de)
|
2004-06-04 |
2011-01-05 |
Teva Pharmaceutical Industries Ltd. |
Irbesartan enthaltende pharmazeutische zusammensetzung
|
US20050271594A1
(en)
*
|
2004-06-04 |
2005-12-08 |
Groenewoud Pieter J |
Abuse resistent pharmaceutical composition
|
PT1828167E
(pt)
|
2004-06-04 |
2014-10-08 |
Debiopharm Int Sa |
Derivados de acrilamida como agentes antibióticos
|
AU2004320488A1
(en)
*
|
2004-06-07 |
2005-12-22 |
Strides Arcolab Limited |
Pharmaceutical composition containing a stable and clear solution of anti-inflammatory drug in soft gelatin capsule and process for producing the same
|
EP1765300A2
(de)
*
|
2004-06-10 |
2007-03-28 |
Duramed Pharmaceuticals, Inc. |
Formulierungen von sumatriptan zur absorption durch biologische membranen, und herstellungs- und anwendungsverfahren
|
LT1765292T
(lt)
|
2004-06-12 |
2018-01-10 |
Collegium Pharmaceutical, Inc. |
Nuo piktnaudžiavimo apsaugotos vaistų formos
|
US8709469B2
(en)
|
2004-06-30 |
2014-04-29 |
Abbott Cardiovascular Systems Inc. |
Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
|
US20060057075A1
(en)
*
|
2004-08-02 |
2006-03-16 |
Moshe Arkin |
Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof
|
DE102004038980A1
(de)
*
|
2004-08-10 |
2006-02-23 |
Cognis Deutschland Gmbh & Co. Kg |
Antibeschlagmittel für Kunststoffe
|
US20080214618A1
(en)
*
|
2004-08-23 |
2008-09-04 |
Auckland Uniservices Limited |
Gastric Therapies Amd Compositions Therefor
|
US20060045914A1
(en)
*
|
2004-08-26 |
2006-03-02 |
Isp Investments Inc. |
Matrix composition for stable microemulsions
|
US7897772B2
(en)
*
|
2004-10-01 |
2011-03-01 |
Kabushiki Kaisha Yakult Honsha |
Acid addition salt of irinotecan
|
US20060088590A1
(en)
*
|
2004-10-22 |
2006-04-27 |
Banner Pharmacaps, Inc. |
Non-blooming gelatin and non-gelatin formulations
|
US20060093675A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Mathew Ebmeier |
Intravaginal treatment of vaginal infections with metronidazole compositions
|
JP2008519784A
(ja)
*
|
2004-11-12 |
2008-06-12 |
イデア アクチェンゲゼルシャフト |
皮膚状態の治療における拡張表面凝集体
|
DK1812072T3
(da)
*
|
2004-11-17 |
2008-12-01 |
Ares Trading Sa |
Benzothiazol-præparat og anvendelse deraf
|
KR20070084531A
(ko)
*
|
2004-11-24 |
2007-08-24 |
머크 앤드 캄파니 인코포레이티드 |
치환된 아미드의 경구 투여용 액체 및 반고체 약제학적제형
|
WO2006076097A2
(en)
*
|
2004-12-07 |
2006-07-20 |
Nektar Therapeutics |
Stable non-crystalline formulation comprising losartan
|
WO2006063109A2
(en)
*
|
2004-12-09 |
2006-06-15 |
Insys Therapeutics, Inc. |
Room-temperature stable dronabinol formulations
|
RS52607B
(en)
*
|
2004-12-24 |
2013-04-30 |
Krka Tovarna Zdravil D.D., Novo Mesto |
SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING VALSARTAN
|
US20060246003A1
(en)
*
|
2004-12-27 |
2006-11-02 |
Eisai Co. Ltd. |
Composition containing anti-dementia drug
|
AU2005320547B2
(en)
|
2004-12-27 |
2009-02-05 |
Eisai R & D Management Co., Ltd. |
Method for stabilizing anti-dementia drug
|
US20070129402A1
(en)
*
|
2004-12-27 |
2007-06-07 |
Eisai Research Institute |
Sustained release formulations
|
MX2007008474A
(es)
|
2005-01-14 |
2008-02-19 |
Chemocentryx Inc |
Sulfonamidas de heteroarilo y ccr2.
|
US7622583B2
(en)
|
2005-01-14 |
2009-11-24 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
CA2598288A1
(en)
*
|
2005-03-03 |
2006-09-14 |
Elan Pharma International Limited |
Nanoparticulate compositions of heterocyclic amide derivatives
|
CA2600054A1
(en)
*
|
2005-03-09 |
2006-09-21 |
Combe Incorporated |
Stable mixed emulsions
|
GB0504950D0
(en)
*
|
2005-03-10 |
2005-04-20 |
Novartis Ag |
Organic compositions
|
WO2006097938A1
(en)
*
|
2005-03-16 |
2006-09-21 |
Strides Arcolab Limited |
Stable liquid suspension formulation comprising tibolone and process for producing the same
|
ES2573539T3
(es)
*
|
2005-03-21 |
2016-06-08 |
Teva Czech Industries S.R.O. |
Inhibidor de la cristalización y su uso en cápsulas de gelatina
|
PE20061303A1
(es)
*
|
2005-03-30 |
2006-12-07 |
Astion Dev As |
Composicion farmaceutica que comprende oxaprozina
|
JP2008534586A
(ja)
*
|
2005-03-30 |
2008-08-28 |
テバ ファーマシューティカル インダストリーズ リミティド |
フェノフィブレートの改良された製剤
|
EP1707197A1
(de)
*
|
2005-03-30 |
2006-10-04 |
Teva Pharmaceutical Industries Ltd. |
Zusammensetzungen, welche Fenofibrat und eine Tensidmischung beinhaltet
|
US20060222692A1
(en)
*
|
2005-03-31 |
2006-10-05 |
Fairfield Clinical Trials Llc |
Method and compositions for transdermal administration of antimicrobial medications
|
HUE061300T2
(hu)
|
2005-04-15 |
2023-06-28 |
Clarus Therapeutics Inc |
Gyógyszer szállítórendszerek hidrofób gyógyszerekhez és az azokat tartalmazó készítmények
|
US8492369B2
(en)
|
2010-04-12 |
2013-07-23 |
Clarus Therapeutics Inc |
Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
|
DE102005017592A1
(de)
*
|
2005-04-16 |
2006-10-19 |
Lindner, Jürgen, Dr. med. |
Darreichungsformen und Kombinationspräparate von Pyrimidinbiosyntheseinhibitoren zur Erzielung zusätzlicher Wirkungen auf das Immunsystem
|
CN1853728A
(zh)
*
|
2005-04-19 |
2006-11-01 |
上海天博生物科技有限公司 |
一种改善药物或营养物口服吸收的方法、配方及其应用
|
US20060240051A1
(en)
*
|
2005-04-26 |
2006-10-26 |
Singleton Andy H |
Eutectic blends containing a water soluble vitamin derivative
|
US8028697B2
(en)
|
2005-04-28 |
2011-10-04 |
Trudell Medical International |
Ventilator circuit and method for the use thereof
|
US20070021411A1
(en)
*
|
2005-05-11 |
2007-01-25 |
Cloyd James C |
Supersaturated benzodiazepine solutions and their delivery
|
WO2006128057A2
(en)
*
|
2005-05-26 |
2006-11-30 |
Duramed Pharmaceuticals, Inc. |
Oral dosage forms comprising progesterone and methods of making and using the same
|
US7767789B2
(en)
*
|
2005-06-02 |
2010-08-03 |
University Hopitals of Cleveland |
Truncated proteins as cancer markers
|
EP1898880A2
(de)
*
|
2005-06-16 |
2008-03-19 |
Warner Chilcott Company Inc. |
Gelzusammensetzungen zur topischen verabreichung
|
EP1904028A1
(de)
*
|
2005-06-16 |
2008-04-02 |
Warner Chilcott Company Inc. |
Östrogenzusammensetzungen zur vaginalen verabreichung
|
US7777035B2
(en)
|
2005-06-22 |
2010-08-17 |
Chemocentryx, Inc. |
Azaindazole compounds and methods of use
|
KR100781882B1
(ko)
|
2005-07-12 |
2007-12-05 |
주식회사유한양행 |
시부트라민을 함유하는 약제학적 조성물
|
US7202209B2
(en)
*
|
2005-07-13 |
2007-04-10 |
Allergan, Inc. |
Cyclosporin compositions
|
US7288520B2
(en)
*
|
2005-07-13 |
2007-10-30 |
Allergan, Inc. |
Cyclosporin compositions
|
US20070015691A1
(en)
|
2005-07-13 |
2007-01-18 |
Allergan, Inc. |
Cyclosporin compositions
|
US7297679B2
(en)
|
2005-07-13 |
2007-11-20 |
Allergan, Inc. |
Cyclosporin compositions
|
US7276476B2
(en)
*
|
2005-07-13 |
2007-10-02 |
Allergan, Inc. |
Cyclosporin compositions
|
US20070015693A1
(en)
*
|
2005-07-13 |
2007-01-18 |
Allergan, Inc. |
Cyclosporin compositions
|
US8067451B2
(en)
*
|
2006-07-18 |
2011-11-29 |
Horizon Pharma Usa, Inc. |
Methods and medicaments for administration of ibuprofen
|
US20080021078A1
(en)
*
|
2006-07-18 |
2008-01-24 |
Horizon Therapeutics, Inc. |
Methods and medicaments for administration of ibuprofen
|
US20080020040A1
(en)
*
|
2006-07-18 |
2008-01-24 |
Horizon Therapeutics, Inc. |
Unit dose form for administration of ibuprofen
|
JP2009501801A
(ja)
*
|
2005-07-18 |
2009-01-22 |
ホライゾン セラピューティクス, インコーポレイテッド |
イブプロフェンとファモチジンとを含有する医薬およびその投与
|
US7501393B2
(en)
|
2005-07-27 |
2009-03-10 |
Allergan, Inc. |
Pharmaceutical compositions comprising cyclosporins
|
US7402325B2
(en)
|
2005-07-28 |
2008-07-22 |
Phoenix Biotechnology, Inc. |
Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander
|
EP1749528A1
(de)
|
2005-08-05 |
2007-02-07 |
Pharma C S.A. |
Pharmazeutische Kombinationen, welche mu-opioid Agonisten und Inhibitoren der Stickstoffmonoxidherstellung enthalten
|
MXPA05009381A
(es)
*
|
2005-09-02 |
2007-03-01 |
Fernando Ahumada Ayala |
Preparaciones para el cuidado de la piel que contienen mupirocina y dipropionato de betametasona.
|
CA2600288A1
(en)
*
|
2005-09-19 |
2007-04-12 |
Combe Incorporated |
Stable emulsion systems with high salt tolerance
|
AU2006294449A1
(en)
*
|
2005-09-29 |
2007-04-05 |
Repros Therapeutics Inc. |
Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
PT2450041T
(pt)
|
2005-10-12 |
2018-11-16 |
Unimed Pharmaceuticals Llc |
Gel de testosterona melhorado e método para a sua utilização
|
US7745400B2
(en)
*
|
2005-10-14 |
2010-06-29 |
Gregg Feinerman |
Prevention and treatment of ocular side effects with a cyclosporin
|
US9839667B2
(en)
|
2005-10-14 |
2017-12-12 |
Allergan, Inc. |
Prevention and treatment of ocular side effects with a cyclosporin
|
TW200800268A
(en)
|
2005-11-04 |
2008-01-01 |
Otsuka Pharma Co Ltd |
Medicinal composition showing improved drug absorbability
|
AU2013213706B2
(en)
*
|
2005-11-07 |
2016-04-14 |
Murty Pharmaceuticals, Inc |
An improved oral dosage form of tetrahydrocannabinol and a method of avoiding and/or suppressing hepatic first pass metabolism via targeted chylomicron/lipoprotein delivery
|
WO2007056242A1
(en)
*
|
2005-11-07 |
2007-05-18 |
Murty Pharmaceuticals, Inc. |
Improved delivery of tetrahydrocannabinol
|
AU2016203127B2
(en)
*
|
2005-11-07 |
2018-07-12 |
Murty Pharmaceuticals, Inc |
An improved oral gastrointestinal dosage form delivery system of cannabinoids and/or standardized marijuana extracts
|
AU2006315514B2
(en)
|
2005-11-10 |
2012-03-01 |
Chemocentryx, Inc. |
Substituted quinolones and methods of use
|
EP2135603B1
(de)
|
2005-11-22 |
2013-01-02 |
Orexigen Therapeutics, Inc. |
Zusammensetzungen und Verfahren zur Erhöhung der Insulinsensitivität
|
AR057946A1
(es)
*
|
2005-11-28 |
2007-12-26 |
Orexigen Therapeutics Inc |
Formulacion de zonisamida de liberacion sostenidda
|
JP2009518399A
(ja)
*
|
2005-12-05 |
2009-05-07 |
アフィニウム ファーマシューティカルズ, インク. |
Fabi阻害剤および抗菌剤としてのヘテロ環アクリルアミド化合物
|
AU2006328328B2
(en)
*
|
2005-12-22 |
2012-08-30 |
Takeda Pharmaceutical Company Limited |
Solid preparation containing an insulin sensitizer
|
US9579297B2
(en)
|
2005-12-28 |
2017-02-28 |
Teikoku Seiyaku Co., Ltd. |
Pharmaceutical composition for application to nail
|
US20090176882A1
(en)
*
|
2008-12-09 |
2009-07-09 |
Depomed, Inc. |
Gastric retentive gabapentin dosage forms and methods for using same
|
US20070178051A1
(en)
*
|
2006-01-27 |
2007-08-02 |
Elan Pharma International, Ltd. |
Sterilized nanoparticulate glucocorticosteroid formulations
|
KR101393652B1
(ko)
|
2006-02-09 |
2014-05-14 |
알바 쎄러퓨틱스 코포레이션 |
폐쇄연접 효과기용 제제
|
US7772273B2
(en)
|
2006-02-10 |
2010-08-10 |
Lifecycle Pharma A/S |
Stabilized atorvastatin
|
US20070190141A1
(en)
*
|
2006-02-16 |
2007-08-16 |
Aaron Dely |
Extended release opiate composition
|
WO2007103555A2
(en)
*
|
2006-03-08 |
2007-09-13 |
Nuviance, Inc. |
Transdermal drug delivery compositions and topical compositions for application on the skin
|
US20070225246A1
(en)
*
|
2006-03-27 |
2007-09-27 |
Denu John M |
O-acetyl-ADP-ribose non-hydrolyzable analogs
|
KR20160033796A
(ko)
*
|
2006-03-28 |
2016-03-28 |
자블린 파머슈티칼스 인코포레이티드 |
저 복용량의 디클로페낙 및 베타-사이클로덱스트린 제형
|
CN101410012A
(zh)
*
|
2006-03-28 |
2009-04-15 |
杰佛林制药公司 |
低剂量的非甾体抗炎药和β-环糊精的制剂
|
US20070238789A1
(en)
*
|
2006-03-31 |
2007-10-11 |
Chin-Ming Chang |
Prednisolone acetate compositions
|
MX2008012794A
(es)
*
|
2006-04-03 |
2008-10-15 |
Teva Pharma |
Microparticulas de farmacos.
|
US20070248668A1
(en)
*
|
2006-04-06 |
2007-10-25 |
Michaelis Arthur F |
Pharmaceutical compositions and uses thereof
|
FR2900048B1
(fr)
*
|
2006-04-21 |
2012-11-16 |
Oreal |
Compositions comprenant un derive diphenyl-methane hydroxyle
|
US20090220436A1
(en)
*
|
2006-05-11 |
2009-09-03 |
Living Proof, Inc. |
In situ polymerization for skin treatment
|
US20080063637A1
(en)
*
|
2006-05-19 |
2008-03-13 |
The Trustees Of Tufts College |
Regulation of oncogenesis by Akt-specific isoforms
|
KR100917809B1
(ko)
|
2006-05-22 |
2009-09-18 |
에스케이케미칼주식회사 |
우수한 저장안정성을 갖는 도세탁셀 함유 주사제 조성물
|
US20100297226A1
(en)
*
|
2006-06-01 |
2010-11-25 |
Dexcel Pharma Technologies Ltd. |
Multiple unit pharmaceutical formulation
|
US8916195B2
(en)
|
2006-06-05 |
2014-12-23 |
Orexigen Therapeutics, Inc. |
Sustained release formulation of naltrexone
|
MY153288A
(en)
*
|
2006-06-28 |
2015-01-29 |
Hovid Berhad |
An effective pharmaceutical carrier for poorly bioavailable drugs
|
US8519135B2
(en)
*
|
2006-07-14 |
2013-08-27 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2/CCR9
|
US20100234364A1
(en)
*
|
2006-07-14 |
2010-09-16 |
Arindrajit Basak |
Ccr2 inhibitors and methods of use thereof
|
ATE498615T1
(de)
|
2006-07-14 |
2011-03-15 |
Chemocentryx Inc |
Triazolylphenylbenzensulfonamide
|
US8067033B2
(en)
*
|
2007-11-30 |
2011-11-29 |
Horizon Pharma Usa, Inc. |
Stable compositions of famotidine and ibuprofen
|
JP5468899B2
(ja)
|
2006-07-20 |
2014-04-09 |
アフィニウム ファーマシューティカルズ, インク. |
Fabiインヒビターとしてのアクリルアミド誘導体
|
US20100260691A1
(en)
*
|
2006-07-31 |
2010-10-14 |
Narayanan Kolazi S |
Aqueous compositions containing a hydrophobic material
|
US20100239629A1
(en)
*
|
2006-07-31 |
2010-09-23 |
Isp Investments Inc. |
Delivery system for delivering bioactive materials
|
AU2007281220B2
(en)
|
2006-07-31 |
2013-08-15 |
Activesite Pharmaceuticals, Inc. |
Inhibitors of plasma kallikrein
|
SG10201503411QA
(en)
|
2006-08-03 |
2015-06-29 |
Nitec Pharma Ag |
Delayed-release glucocorticoid treatment of rheumatoid disease
|
WO2008019146A2
(en)
*
|
2006-08-04 |
2008-02-14 |
Insys Therapeutics Inc. |
Aqueous dronabinol formulations
|
WO2008021666A2
(en)
*
|
2006-08-18 |
2008-02-21 |
Morton Grove Pharmaceuticals, Inc. |
Stable liquid levetiracetam compositions and methods
|
EP2063873A2
(de)
*
|
2006-08-31 |
2009-06-03 |
Horizon Therapeutics, Inc. |
Nsaid-dosierungseinheitsformulierungen mit h2-rezeptor-antagonisten und verfahren zu ihrer verwendung
|
US9744137B2
(en)
|
2006-08-31 |
2017-08-29 |
Supernus Pharmaceuticals, Inc. |
Topiramate compositions and methods of enhancing its bioavailability
|
DK2066179T3
(en)
*
|
2006-09-01 |
2016-09-26 |
Du Pont |
FORMULATIONS CONTAINING INDOXACARB FOR LOCAL, TOPICAL ADMINISTRATION
|
JP4717769B2
(ja)
*
|
2006-09-20 |
2011-07-06 |
辻製油株式会社 |
油溶性物質含有可溶化組成物の製造方法
|
US20080075785A1
(en)
*
|
2006-09-22 |
2008-03-27 |
San-Laung Chow |
Controlled release hydrogel formulation
|
US20110165236A1
(en)
*
|
2006-09-22 |
2011-07-07 |
Biokey, Inc. |
Controlled release hydrogel formulation
|
US8747871B2
(en)
*
|
2006-09-28 |
2014-06-10 |
Isp Investments Inc. |
Synergistic matrix composite for making stable microemulsions of active ingredients
|
EP2068825B1
(de)
|
2006-10-04 |
2011-01-26 |
M & P Patent Aktiengesellschaft |
Abgabesystem mit gesteuerter freisetzung zur nasalen anwendung von neurotransmittern
|
US20090092658A1
(en)
*
|
2007-10-05 |
2009-04-09 |
Santarus, Inc. |
Novel formulations of proton pump inhibitors and methods of using these formulations
|
MX2009004874A
(es)
|
2006-11-09 |
2009-06-16 |
Orexigen Therapeutics Inc |
Formulaciones farmaceuticas estratificadas que comprenden una capa intermediaria que se disuelve rapidamente.
|
CN101573103A
(zh)
|
2006-11-09 |
2009-11-04 |
奥雷西根治疗公司 |
用于施用重量减轻药物的单位剂量包装和方法
|
JP5489719B2
(ja)
|
2006-11-17 |
2014-05-14 |
スパーナス ファーマシューティカルズ インコーポレイテッド |
トピラマートの徐放性配合物
|
US8430055B2
(en)
|
2008-08-29 |
2013-04-30 |
Lutonix, Inc. |
Methods and apparatuses for coating balloon catheters
|
US20080276935A1
(en)
|
2006-11-20 |
2008-11-13 |
Lixiao Wang |
Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
|
US8425459B2
(en)
*
|
2006-11-20 |
2013-04-23 |
Lutonix, Inc. |
Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
|
US9737640B2
(en)
|
2006-11-20 |
2017-08-22 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US8414526B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
|
US8998846B2
(en)
|
2006-11-20 |
2015-04-07 |
Lutonix, Inc. |
Drug releasing coatings for balloon catheters
|
US8414525B2
(en)
*
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US8414910B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US9700704B2
(en)
|
2006-11-20 |
2017-07-11 |
Lutonix, Inc. |
Drug releasing coatings for balloon catheters
|
US8414909B2
(en)
*
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
GB0623838D0
(en)
|
2006-11-29 |
2007-01-10 |
Malvern Cosmeceutics Ltd |
Novel compositions
|
JP5721326B2
(ja)
*
|
2006-12-04 |
2015-05-20 |
スパーナス ファーマシューティカルズ インコーポレイテッド |
トピラマートの増強即時放出配合物
|
WO2008097953A2
(en)
*
|
2007-02-05 |
2008-08-14 |
Wyeth |
Pharmaceutical compositions containing substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
|
WO2008098374A1
(en)
|
2007-02-16 |
2008-08-21 |
Affinium Pharmaceuticals, Inc. |
Salts, prodrugs and polymorphs of fab i inhibitors
|
ES2350029T3
(es)
*
|
2007-03-02 |
2011-01-17 |
Farnam Companies, Inc. |
Pellets de liberación sostenida que comprenden un material tipo cera.
|
GB0704709D0
(en)
*
|
2007-03-12 |
2007-04-18 |
Croda Singapore P L |
Dispersion, gel and emulsification system
|
EP2061440A2
(de)
|
2007-04-04 |
2009-05-27 |
Sigmoid Pharma Limited |
Pharmazeutische tacrolimus-zusammensetzung
|
US8309222B2
(en)
*
|
2007-04-25 |
2012-11-13 |
Covidien Lp |
Coated filaments
|
CA2685118C
(en)
|
2007-04-26 |
2016-11-01 |
Sigmoid Pharma Limited |
Manufacture of multiple minicapsules
|
DK2152078T3
(da)
|
2007-04-27 |
2021-02-08 |
Cydex Pharmaceuticals Inc |
Formuleringer indeholdende clopidogrel og sulfoalkylethercyclodextrin og anvendelsesfremgangsmåder
|
ES2600477T3
(es)
|
2007-05-22 |
2017-02-09 |
Chemocentryx, Inc. |
3-(Imidazolil)-pirazolo[3,4-b]piridinas
|
WO2008143361A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Otsuka Pharmaceutical Co., Ltd. |
A medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease
|
KR20150064232A
(ko)
*
|
2007-05-25 |
2015-06-10 |
더 유니버시티 오브 브리티쉬 콜롬비아 |
치료제의 경구 투여를 위한 제제 및 관련 방법
|
MX354603B
(es)
|
2007-05-25 |
2018-03-13 |
Indivior Uk Ltd |
Formulaciones de transferencia sostenida de compuestos de risperidona.
|
US7776877B2
(en)
|
2007-06-22 |
2010-08-17 |
Chemocentryx, Inc. |
N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
|
US20090004284A1
(en)
*
|
2007-06-26 |
2009-01-01 |
Watson Pharmaceuticals, Inc. |
Controlled release tamsulosin hydrochloride formulation
|
CN101820881B
(zh)
*
|
2007-07-12 |
2013-05-01 |
坎莫森特里克斯公司 |
作为ccr2调节剂用于治疗炎症的稠合杂芳基吡啶基和苯基苯磺酰胺
|
CA2698752A1
(en)
*
|
2007-08-06 |
2009-02-12 |
Insys Therapeutics Inc. |
Oral cannabinoid liquid formulations and methods of treatment
|
GB2451811A
(en)
*
|
2007-08-09 |
2009-02-18 |
Ems Sa |
Delivery composition for solubilising water-insoluble pharmaceutical active ingredients
|
US20090062244A1
(en)
*
|
2007-09-04 |
2009-03-05 |
Joseph Schwarz |
Pharmaceutical composition
|
JP2010539245A
(ja)
|
2007-09-14 |
2010-12-16 |
日東電工株式会社 |
薬物担体
|
EP2200613B1
(de)
|
2007-09-21 |
2018-09-05 |
The Johns Hopkins University |
Phenazin-derivate und ihre verwendungen
|
CA3014633C
(en)
*
|
2007-10-08 |
2022-05-17 |
Aurinia Pharmaceuticals Inc. |
Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors
|
US8661630B2
(en)
|
2008-05-21 |
2014-03-04 |
Abbott Cardiovascular Systems Inc. |
Coating comprising an amorphous primer layer and a semi-crystalline reservoir layer
|
US20090130198A1
(en)
*
|
2007-11-21 |
2009-05-21 |
Innopharmax Inc. |
Pharmaceutical composition with enhanced bioavailability
|
WO2009066299A2
(en)
*
|
2007-11-23 |
2009-05-28 |
Rappaport Family Institute For Research |
Use of haptoglobin genotyping in diagnosis and treatment of cardiovascular disease
|
FR2924937B1
(fr)
*
|
2007-12-14 |
2013-05-17 |
Oreal |
Composition antitranspirante et/ou deodorante solide sous forme d'emulsion eau-dans-huile a base d'emulsionnants silicone et de cires ; procede de traitement des odeurs corporelles
|
WO2009087678A2
(en)
*
|
2007-12-24 |
2009-07-16 |
Sun Pharma Advanced Research Company Limited |
Nanodispersion
|
PL2240018T3
(pl)
|
2008-01-04 |
2017-01-31 |
Schabar Res Ass Llc |
Kompozycja zawierająca środek przeciwbólowy i przeciwhistaminowy
|
US7893097B2
(en)
|
2008-02-02 |
2011-02-22 |
Dow Pharmaceutical Sciences, Inc. |
Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water
|
JP2011515331A
(ja)
*
|
2008-02-06 |
2011-05-19 |
バイオサスペンションズ・リミテッド |
新規組成物及びその使用
|
WO2009100394A2
(en)
*
|
2008-02-08 |
2009-08-13 |
Terumo Kabushiki Kaisha |
Device for local intraluminal transport of a biologically and physiologically active agent
|
AU2009214443B2
(en)
*
|
2008-02-13 |
2013-10-10 |
Board Of Regents, The University Of Texas System |
Templated open flocs of anisotropic particles for enhanced pulmonary delivery
|
WO2009117422A2
(en)
|
2008-03-17 |
2009-09-24 |
Discovery Laboratories, Inc. |
Ventilation circuit adaptor and proximal aerosol delivery system
|
US8409601B2
(en)
|
2008-03-31 |
2013-04-02 |
Cordis Corporation |
Rapamycin coated expandable devices
|
US8420110B2
(en)
*
|
2008-03-31 |
2013-04-16 |
Cordis Corporation |
Drug coated expandable devices
|
CA2725930A1
(en)
|
2008-05-30 |
2009-12-30 |
Orexigen Therapeutics, Inc. |
Methods for treating visceral fat conditions
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
FR2932682B1
(fr)
*
|
2008-06-23 |
2013-07-12 |
Bionetwork |
Nouvelles formes pharmaceutiques a effet rapide et les utilisations des compositions pharmaceutiques ainsi obtenus.
|
EP2306989A2
(de)
*
|
2008-07-03 |
2011-04-13 |
Panacea Biotec Limited |
Fenofibrat-formulierung mit erhöhter oraler bioverfügbarkeit
|
US8575189B2
(en)
*
|
2008-10-08 |
2013-11-05 |
Takata Seiyaku Co., Ltd. |
Tacrolimus preparation for external applications
|
ES2402241T3
(es)
|
2008-10-22 |
2013-04-30 |
Trudell Medical International |
Sistema de suministro de aerosol modular
|
US10463677B2
(en)
|
2008-11-07 |
2019-11-05 |
Cydex Pharmaceuticals, Inc. |
Composition containing sulfoalkyl ether cyclodextrin and latanoprost
|
JO3346B1
(ar)
|
2008-12-22 |
2019-03-13 |
Chemocentryx Inc |
مواد مضادة C5aR
|
JP5793084B2
(ja)
|
2008-12-23 |
2015-10-14 |
ギリアド ファーマセット エルエルシー |
プリンヌクレオシドの合成
|
MX2011006890A
(es)
|
2008-12-23 |
2011-07-20 |
Pharmasset Inc |
Analogos de nucleosidos.
|
TW201026715A
(en)
|
2008-12-23 |
2010-07-16 |
Pharmasset Inc |
Nucleoside phosphoramidates
|
EP2204167A1
(de)
|
2009-01-05 |
2010-07-07 |
Azad Pharma AG |
Pharmazeutische Mikroemulsion zur Prävention von supramolekularer Aggregation von ampiphilen Molekülen
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
AU2010207740B2
(en)
*
|
2009-01-26 |
2016-06-16 |
Nitec Pharma Ag |
Delayed-release glucocorticoid treatment of asthma
|
NZ582836A
(en)
*
|
2009-01-30 |
2011-06-30 |
Nitec Pharma Ag |
Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage
|
US20100209475A1
(en)
*
|
2009-02-19 |
2010-08-19 |
Biomet Manufacturing Corp. |
Medical implants having a drug delivery coating
|
US8101593B2
(en)
|
2009-03-03 |
2012-01-24 |
Kythera Biopharmaceuticals, Inc. |
Formulations of deoxycholic acid and salts thereof
|
KR101072600B1
(ko)
*
|
2009-04-09 |
2011-10-11 |
한올바이오파마주식회사 |
플루바스타틴을 포함하는 안정한 약제학적 조성물 및 그의 제조방법
|
US20100297194A1
(en)
*
|
2009-04-30 |
2010-11-25 |
Nathaniel Catron |
Formulation for oral administration of apoptosis promoter
|
US20100280031A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Paul David |
Lipid formulation of apoptosis promoter
|
US8362013B2
(en)
*
|
2009-04-30 |
2013-01-29 |
Abbvie Inc. |
Salt of ABT-263 and solid-state forms thereof
|
US20100278921A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Fischer Cristina M |
Solid oral formulation of abt-263
|
US8728516B2
(en)
*
|
2009-04-30 |
2014-05-20 |
Abbvie Inc. |
Stabilized lipid formulation of apoptosis promoter
|
ES2769949T3
(es)
|
2009-05-13 |
2020-06-29 |
Cydex Pharmaceuticals Inc |
Composiciones farmacéuticas que comprenden prasugrel y derivados de ciclodextrina y métodos de preparación y uso de las mismas
|
GB2483815B
(en)
|
2009-05-18 |
2013-12-25 |
Sigmoid Pharma Ltd |
Composition comprising oil drops
|
TWI576352B
(zh)
|
2009-05-20 |
2017-04-01 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
EP2255786A1
(de)
*
|
2009-05-25 |
2010-12-01 |
HRA Pharma LLC |
Selbstmikroemulgierende Mitotanzusammensetzung
|
GB2483419B
(en)
|
2009-06-03 |
2015-04-08 |
Sequessome Technology Holdings Ltd |
Formulations for the treatment of deep tissue pain
|
TWI471321B
(zh)
*
|
2009-06-08 |
2015-02-01 |
Abbott Gmbh & Co Kg |
Bcl-2族群抑制劑之口服醫藥劑型
|
TWI532484B
(zh)
*
|
2009-06-08 |
2016-05-11 |
艾伯維有限公司 |
包含凋亡促進劑之固態分散劑
|
US8778364B2
(en)
|
2009-06-19 |
2014-07-15 |
Sun Pharma Advanced Research Company Ltd. |
Nanodispersion of a drug and process for its preparation
|
WO2010148288A2
(en)
*
|
2009-06-19 |
2010-12-23 |
Lyotropic Therapeutics, Inc. |
Pharmaceutical formulations with low aqueous levels of free unbound drug
|
WO2010150144A2
(en)
|
2009-06-25 |
2010-12-29 |
Wockhardt Research Centre |
Low dose pharmaceutical compositions of celecoxib
|
SG177569A1
(en)
|
2009-07-07 |
2012-03-29 |
Boehringer Ingelheim Int |
Pharmaceutical composition for a hepatitis c viral protease inhibitor
|
MX336482B
(es)
|
2009-08-21 |
2016-01-21 |
Henk-Andre Kroon |
Formulaciones vesiculares.
|
CN102574789B
(zh)
|
2009-09-21 |
2014-12-10 |
凯莫森特里克斯股份有限公司 |
吡咯烷酮甲酰胺衍生物作为趋化素-r(chemr23)调节剂
|
US11337962B2
(en)
|
2009-09-25 |
2022-05-24 |
Upsher-Smith Laboratories, Llc |
Formulations comprising triptan compounds
|
WO2011036521A2
(en)
|
2009-09-25 |
2011-03-31 |
Dr. Reddy's Laboratories Limited |
Formulations comprising triptan compounds
|
EP2488029B1
(de)
|
2009-09-30 |
2016-03-23 |
Acura Pharmaceuticals, Inc. |
Verfahren und zusammensetzungen zur abschreckung vor missbrauch
|
WO2011050457A1
(en)
|
2009-10-26 |
2011-05-05 |
The University Of British Columbia |
Stabilized formulation for oral administration of therapeutic agents and related methods
|
MX2012005264A
(es)
|
2009-11-09 |
2012-07-03 |
Capsugel Belgium Nv |
Portador de suministro.
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
KR20120098915A
(ko)
*
|
2009-12-22 |
2012-09-05 |
아보트 러보러터리즈 |
Abt?263 캡슐제
|
US20110160168A1
(en)
|
2009-12-31 |
2011-06-30 |
Differential Drug Development Associates, Llc |
Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols
|
CN102724878A
(zh)
|
2010-01-11 |
2012-10-10 |
奥雷西根治疗公司 |
在重度抑郁症患者中提供体重减轻疗法的方法
|
US8603568B2
(en)
|
2010-01-15 |
2013-12-10 |
Kemin Industries, Inc. |
Hydrolyzed lecithin product to improve digestibility
|
TWI438009B
(zh)
*
|
2010-02-19 |
2014-05-21 |
Teikoku Pharma Usa Inc |
紫杉烷前-乳劑調配物及其製造與使用之方法
|
JP5283654B2
(ja)
*
|
2010-03-30 |
2013-09-04 |
中日本カプセル 株式会社 |
ソフトカプセル用の充填組成物
|
PL3290428T3
(pl)
|
2010-03-31 |
2022-02-07 |
Gilead Pharmasset Llc |
Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
|
PT2552930E
(pt)
|
2010-03-31 |
2015-11-17 |
Gilead Pharmasset Llc |
2-(((s)-(((2r,3r,4r,5r)-5-(2,4-dioxo-3,4-dihidropirimidin- 1-(2h)-il)-4-fluoro-3-hidroxi-4-metiltetrahidrofuran-2- il)metoxi) (fenoxi)fosforil)amino)propanoato de (s)- isopropilo cristalino
|
UY33310A
(es)
|
2010-03-31 |
2011-10-31 |
Pharmasset Inc |
Sintesis estereoselectiva de activos que contienen fosforo
|
US8685433B2
(en)
|
2010-03-31 |
2014-04-01 |
Abbott Cardiovascular Systems Inc. |
Absorbable coating for implantable device
|
MX341082B
(es)
|
2010-05-03 |
2016-08-08 |
Teikoku Pharma Usa Inc |
Formulaciones de pro-emulsion de taxano no acuosas y metodos para hacer y usar las mismas.
|
US9272044B2
(en)
|
2010-06-08 |
2016-03-01 |
Indivior Uk Limited |
Injectable flowable composition buprenorphine
|
GB2513060B
(en)
|
2010-06-08 |
2015-01-07 |
Rb Pharmaceuticals Ltd |
Microparticle buprenorphine suspension
|
US9375437B2
(en)
|
2010-06-18 |
2016-06-28 |
Lipocine Inc. |
Progesterone containing oral dosage forms and kits
|
EP2585051B2
(de)
|
2010-06-23 |
2020-04-08 |
KRKA, tovarna zdravil, d.d., Novo mesto |
Pharmazeutische orale dosierformen mit lercandipin und enalapril und ihren pharmazeutisch akzeptablen salzen
|
PE20131096A1
(es)
|
2010-08-04 |
2013-10-10 |
Gruenenthal Chemie |
Forma de dosificacion farmaceutica que comprende 6'-fluoro-(n-metil-o n,n-dimetil)-4-fenil-4',9-dihidro-3'h-espiro[ciclohxan-1,1'-pirano[3,4,b]indol]-4-amina para el tratamiento de dolor neuropatico
|
DK2600846T3
(en)
*
|
2010-08-04 |
2016-01-11 |
Gruenenthal Gmbh |
PHARMACEUTICAL DOSAGE FORM COMPRISING 6'-fluoro- (N-methyl or N, N-dimethyl -) - 4-phenyl-4 ', 9'-dihydro-3'H-spiro [cyclohexane-1,1'-pyrano [3 , 4, b] indole] -4-amine
|
MY158809A
(en)
*
|
2010-09-22 |
2016-11-15 |
Craun Res Sdn Bhd |
Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same
|
CN103209677B
(zh)
|
2010-10-01 |
2015-08-19 |
玫琳凯有限公司 |
皮肤增湿剂和老化抑制配制剂
|
WO2012053306A1
(ja)
*
|
2010-10-22 |
2012-04-26 |
学校法人 福岡大学 |
胃上皮性腫瘍(腺腫・胃癌)の診断に有用な白色不透明物質を応用した内視鏡観察法および診断能改善組成物
|
US8865198B2
(en)
|
2010-10-25 |
2014-10-21 |
Dexcel Pharma Technologies Ltd. |
Method for treating a periodontal disease
|
US10695431B2
(en)
|
2010-10-29 |
2020-06-30 |
Infirst Healthcare Limited |
Solid solution compositions and use in cardiovascular disease
|
US9308213B2
(en)
|
2010-10-29 |
2016-04-12 |
Infirst Healthcare Limited |
Solid solution compositions and use in chronic inflammation
|
UA113500C2
(xx)
|
2010-10-29 |
2017-02-10 |
|
Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб
|
US9504664B2
(en)
|
2010-10-29 |
2016-11-29 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
US9271950B2
(en)
|
2010-10-29 |
2016-03-01 |
Infirst Healthcare Limited |
Compositions for treating chronic inflammation and inflammatory diseases
|
US9737500B2
(en)
|
2010-10-29 |
2017-08-22 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
US11202831B2
(en)
|
2010-10-29 |
2021-12-21 |
Infirst Healthcare Limited |
Solid solution compositions and use in cardiovascular disease
|
US9744132B2
(en)
|
2010-10-29 |
2017-08-29 |
Infirst Healthcare Limited |
Solid solution compositions and use in chronic inflammation
|
US10695432B2
(en)
|
2010-10-29 |
2020-06-30 |
Infirst Healthcare Limited |
Solid solution compositions and use in severe pain
|
US11730709B2
(en)
|
2010-10-29 |
2023-08-22 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
US8895537B2
(en)
|
2010-10-29 |
2014-11-25 |
Infirst Healthcare Ltd. |
Compositions and methods for treating cardiovascular diseases
|
US11224659B2
(en)
|
2010-10-29 |
2022-01-18 |
Infirst Healthcare Limited |
Solid solution compositions and use in severe pain
|
FR2967351B1
(fr)
*
|
2010-11-15 |
2016-06-10 |
Oreal |
Composition cosmetique solide sous forme de poudre compacte
|
FR2967350B1
(fr)
*
|
2010-11-15 |
2015-05-01 |
Oreal |
Composition cosmetique solide sous forme de poudre compacte
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
CA2818853A1
(en)
|
2010-11-30 |
2012-06-07 |
Gilead Pharmasset Llc |
2'-spirocyclo-nucleosides for use in therapy of hcv or dengue virus
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
EP2654729B1
(de)
|
2010-12-24 |
2016-05-04 |
KRKA, d.d., Novo mesto |
Orale homogene pharmazeutische zubereitung enthaltend lercanidipine und enalapril oder ihre pharmazeutische salze zusammen mit einer organischen säure
|
US20120172796A1
(en)
*
|
2010-12-30 |
2012-07-05 |
Chappa Ralph A |
Composition for intravascular delivery of therapeutic composition
|
MX363465B
(es)
|
2011-02-18 |
2019-03-25 |
Kythera Biopharmaceuticals Inc |
Tratamiento de la grasa submental.
|
EP2685962A1
(de)
|
2011-03-17 |
2014-01-22 |
Transdermal Biotechnology, Inc. |
Topische stickoxidsysteme sowie verfahren zu ihrer verwendung
|
US8653058B2
(en)
|
2011-04-05 |
2014-02-18 |
Kythera Biopharmaceuticals, Inc. |
Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
|
WO2012142308A1
(en)
|
2011-04-13 |
2012-10-18 |
Activesite Pharmaceuticals, Inc. |
Prodrugs of inhibitors of plasma kallikrein
|
US20130045958A1
(en)
|
2011-05-13 |
2013-02-21 |
Trimel Pharmaceuticals Corporation |
Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
|
US9757388B2
(en)
|
2011-05-13 |
2017-09-12 |
Acerus Pharmaceuticals Srl |
Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
|
US20130040923A1
(en)
|
2011-05-13 |
2013-02-14 |
Trimel Pharmaceuticals Corporation |
Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
|
JP5885397B2
(ja)
*
|
2011-05-18 |
2016-03-15 |
東洋精糖株式会社 |
難水溶性物質の溶解方法およびその利用
|
WO2012159960A1
(en)
*
|
2011-05-20 |
2012-11-29 |
Aventis Pharmaceuticals Inc. |
Pharmaceutical composition comprising fexofenadine
|
EP2734198A4
(de)
*
|
2011-06-24 |
2015-04-15 |
Acenda Pharma Inc |
Verfahren und verbesserte pharmazeutische zusammensetzung zur verbesserung der absorption eines esterprodrugs
|
EP2731460A1
(de)
*
|
2011-07-15 |
2014-05-21 |
Prayon |
Formulierung von transparenten und nährstoffreichen mikroemulsionen
|
US8951996B2
(en)
|
2011-07-28 |
2015-02-10 |
Lipocine Inc. |
17-hydroxyprogesterone ester-containing oral compositions and related methods
|
KR102162901B1
(ko)
|
2011-09-29 |
2020-10-08 |
피엘엑스 옵코 인코포레이티드 |
위장관을 따라 약물을 표적화 방출하기 위한 pH 감응성 담체, 그로부터의 조성물, 및 이들의 제조 및 사용 방법
|
WO2013057208A1
(en)
|
2011-10-18 |
2013-04-25 |
Targeted Delivery Technologies Limited |
Compositions and methods for reducing the proliferation and viability of microbial agents
|
TWI619496B
(zh)
|
2011-11-03 |
2018-04-01 |
台灣微脂體股份有限公司 |
疏水性喜樹鹼衍生物之醫藥組合物
|
US10980798B2
(en)
|
2011-11-03 |
2021-04-20 |
Taiwan Liposome Company, Ltd. |
Pharmaceutical compositions of hydrophobic camptothecin derivatives
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
EP3936133A1
(de)
|
2011-11-23 |
2022-01-12 |
TherapeuticsMD, Inc. |
Natürliche kombinationshormonersatzformulierungen und therapien
|
WO2013082429A1
(en)
|
2011-12-01 |
2013-06-06 |
Chemocentryx, Inc. |
Substituted benzimidazoles and benzopyrazoles as ccr(4) antagonists
|
WO2013082490A1
(en)
|
2011-12-01 |
2013-06-06 |
Chemocentryx, Inc. |
Substituted anilines as ccr(4) antagonists
|
TW201330851A
(zh)
*
|
2012-01-20 |
2013-08-01 |
Renascence Therapeutics Ltd |
用於鼻內施用唑吡坦(zolpidem)的治療組合物
|
BR112014018439A8
(pt)
*
|
2012-01-26 |
2017-07-11 |
Therapeuticsmd Inc |
Terapias de reposição de hormônio transdérmica
|
ES2645617T3
(es)
|
2012-02-29 |
2017-12-07 |
Chemocentryx, Inc. |
Pirazol-1-il benceno sulfonamidas como antagonistas del CCR9
|
US8993614B2
(en)
|
2012-03-15 |
2015-03-31 |
F. Hoffmann-La Roche Ag |
Substituted pyrrolidine-2-carboxamides
|
GB201205642D0
(en)
|
2012-03-29 |
2012-05-16 |
Sequessome Technology Holdings Ltd |
Vesicular formulations
|
EA201791738A1
(ru)
|
2012-05-09 |
2018-03-30 |
Вестерн Юниверсити Оф Хелт Сайенсиз |
Пролипосомальные композиции тестостерона
|
GB201208384D0
(en)
|
2012-05-14 |
2012-06-27 |
Sequessome Technology Holdings Ltd |
Vesicular formulations, uses and methods
|
GB201208409D0
(en)
|
2012-05-14 |
2012-06-27 |
Sequessome Technology Holdings Ltd |
Vesicular formulations, kits and uses
|
RS60682B1
(sr)
|
2012-06-06 |
2020-09-30 |
Nalpropion Pharmaceuticals Llc |
Kompozicija za upotrebu u postupku lečenja prekomerne težine i gojaznosti kod pacijenata sa visokim kardiovaskularnim rizikom
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US9078925B2
(en)
|
2012-06-18 |
2015-07-14 |
Galephar Pharmaceutical Research, Inc. |
Pharmaceutical semi-solid composition of isotretinoin
|
RU2020140867A
(ru)
*
|
2012-06-18 |
2021-06-10 |
Терапьютиксмд, Инк. |
Капсулы с растворимым эстрадиолом для интравагинального введения
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
LT2861608T
(lt)
|
2012-06-19 |
2019-07-10 |
Debiopharm International Sa |
(e)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-okso-5,6,7,8-tetrahidro-1,8-nafthidrin-3-il)akrilamido provaisto dariniai
|
GB201212010D0
(en)
|
2012-07-05 |
2012-08-22 |
Sigmoid Pharma Ltd |
Formulations
|
US8871258B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Treatment and prevention of learning and memory disorders
|
US8871256B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Methods and systems for treatment of inflammatory diseases with nitric oxide
|
US8871254B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
|
US8871255B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Treatment of skin and soft tissue infection with nitric oxide
|
US8871261B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Cancer treatments and compositions for use thereof
|
US8871262B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Compositions and methods for treatment of osteoporosis and other indications
|
US8871257B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
|
US8871260B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Methods and compositions for muscular and neuromuscular diseases
|
US8871259B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Techniques and systems for treatment of neuropathic pain and other indications
|
JO3685B1
(ar)
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
|
AU2013352162B2
(en)
|
2012-11-30 |
2018-08-16 |
Acura Pharmaceuticals, Inc. |
Self-regulated release of active pharmaceutical ingredient
|
ES2707323T3
(es)
|
2012-12-07 |
2019-04-03 |
Chemocentryx Inc |
Diazol lactamas
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
DK2935227T3
(en)
|
2012-12-21 |
2017-12-04 |
Chemocentryx Inc |
DIAZOLAMIDES AS CCR1 RECEPTOR ANTAGONISTS
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
JP6474732B2
(ja)
|
2013-01-14 |
2019-02-27 |
インファースト ヘルスケア リミテッド |
激痛治療用組成物と方法
|
MX366317B
(es)
|
2013-02-04 |
2019-07-03 |
Infirst Healthcare Ltd |
Composiciones y metodos para tratar la inflamacion cronica y las enfermedades inflamatorias.
|
US20160000799A1
(en)
|
2013-02-21 |
2016-01-07 |
Dr. Reddy's Laboratories Ltd. |
Pharmaceutical compositions of cetp inhibitors
|
GB201304662D0
(en)
|
2013-03-14 |
2013-05-01 |
Sigmoid Pharma Ltd |
Compositions
|
US9314433B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Methods and systems for treating or preventing cancer
|
US9320758B2
(en)
|
2013-03-13 |
2016-04-26 |
Transdermal Biotechnology, Inc. |
Brain and neural treatments comprising peptides and other compositions
|
US9687520B2
(en)
|
2013-03-13 |
2017-06-27 |
Transdermal Biotechnology, Inc. |
Memory or learning improvement using peptide and other compositions
|
US9314422B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Peptide systems and methods for metabolic conditions
|
US9320706B2
(en)
|
2013-03-13 |
2016-04-26 |
Transdermal Biotechnology, Inc. |
Immune modulation using peptides and other compositions
|
US9314423B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Hair treatment systems and methods using peptides and other compositions
|
US20140271938A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Systems and methods for delivery of peptides
|
US9295637B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Compositions and methods for affecting mood states
|
US20140271731A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Cardiovascular disease treatment and prevention
|
US9295636B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Wound healing using topical systems and methods
|
US9393265B2
(en)
|
2013-03-13 |
2016-07-19 |
Transdermal Biotechnology, Inc. |
Wound healing using topical systems and methods
|
US9339457B2
(en)
|
2013-03-13 |
2016-05-17 |
Transdermal Biotechnology, Inc. |
Cardiovascular disease treatment and prevention
|
US9393264B2
(en)
|
2013-03-13 |
2016-07-19 |
Transdermal Biotechnology, Inc. |
Immune modulation using peptides and other compositions
|
US9241899B2
(en)
|
2013-03-13 |
2016-01-26 |
Transdermal Biotechnology, Inc. |
Topical systems and methods for treating sexual dysfunction
|
US9314417B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Treatment of skin, including aging skin, to improve appearance
|
US9849160B2
(en)
|
2013-03-13 |
2017-12-26 |
Transdermal Biotechnology, Inc. |
Methods and systems for treating or preventing cancer
|
US9295647B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Systems and methods for delivery of peptides
|
US20140271937A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Brain and neural treatments comprising peptides and other compositions
|
US9724419B2
(en)
|
2013-03-13 |
2017-08-08 |
Transdermal Biotechnology, Inc. |
Peptide systems and methods for metabolic conditions
|
US9387159B2
(en)
|
2013-03-13 |
2016-07-12 |
Transdermal Biotechnology, Inc. |
Treatment of skin, including aging skin, to improve appearance
|
US9750787B2
(en)
|
2013-03-13 |
2017-09-05 |
Transdermal Biotechnology, Inc. |
Memory or learning improvement using peptide and other compositions
|
CN105188670B
(zh)
|
2013-03-15 |
2018-11-02 |
马留斯医药有限责任公司 |
乳液制剂
|
US11744838B2
(en)
|
2013-03-15 |
2023-09-05 |
Acerus Biopharma Inc. |
Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
|
US9040034B2
(en)
|
2013-04-09 |
2015-05-26 |
International Business Machines Corporation |
Vitamin functionalized gel-forming block copolymers for biomedical applications
|
BR112016002917B1
(pt)
*
|
2013-08-14 |
2020-07-28 |
Croda, Inc |
formulação agroquímica, formulação concentrada, e, método para tratamento de vegetação para controlar pestes
|
US9539185B2
(en)
*
|
2013-09-30 |
2017-01-10 |
L'oreal |
Self-foaming cleansing system
|
IN2013MU03370A
(de)
*
|
2013-10-25 |
2015-09-25 |
Cipla Ltd |
|
EP3076968B1
(de)
|
2013-12-02 |
2019-04-17 |
ChemoCentryx, Inc. |
Ccr6-verbindungen
|
US20160317542A1
(en)
|
2013-12-09 |
2016-11-03 |
Respira Therapeutics, Inc. |
Pde5 inhibitor powder formulations and methods relating thereto
|
WO2015094925A1
(en)
|
2013-12-18 |
2015-06-25 |
Capsugel Belgium Nv |
Stable liquid filled hard capsule comprising beta-hydroxy-beta-methylbutyric acid
|
EP3089737B1
(de)
|
2013-12-31 |
2021-11-03 |
Rapamycin Holdings, LLC |
Orale rapamycinnanopartikelzubereitungen und verwendung
|
US10143657B2
(en)
|
2014-01-17 |
2018-12-04 |
Oncoral Pharma Aps |
Solid oral dosage form of irinotecan for the treatment of cancer
|
EP3104840B8
(de)
|
2014-02-11 |
2019-07-10 |
Latitude Pharmaceuticals Inc. |
Parenterale zusammensetzungen von celecoxib
|
GB201404139D0
(en)
|
2014-03-10 |
2014-04-23 |
Rb Pharmaceuticals Ltd |
Sustained release buprenorphine solution formulations
|
AU2015237723B2
(en)
|
2014-03-26 |
2018-04-26 |
Sun Pharma Advanced Research Company Ltd. |
Abuse deterrent immediate release biphasic matrix solid dosage form
|
EA035866B1
(ru)
|
2014-04-02 |
2020-08-21 |
Минорикс Терапьютикс С.Л. |
Применение производных 2,4-тиазолидиндиона для лечения расстройств центральной нервной системы и способ лечения с использованием таких производных
|
WO2015179782A1
(en)
|
2014-05-22 |
2015-11-26 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
HUE061928T2
(hu)
|
2014-06-11 |
2023-09-28 |
SpecGx LLC |
Különbözõ oldódási profillal rendelkezõ porlasztva szárított készítmények és elõállításukhoz szükséges eljárások
|
EP3174542A4
(de)
|
2014-07-29 |
2018-01-03 |
TherapeuticsMD, Inc. |
Transdermale creme
|
WO2016033556A1
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
|
US20170246187A1
(en)
|
2014-08-28 |
2017-08-31 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
JP6716582B2
(ja)
|
2014-11-07 |
2020-07-01 |
サブリミティ・セラピューティクス・リミテッドSublimity Therapeutics Limited |
シクロスポリンを含む組成物
|
WO2016105499A1
(en)
|
2014-12-23 |
2016-06-30 |
Intellectual Property Associates, Llc |
Methods and formulations for transdermal administration
|
WO2016105465A1
(en)
*
|
2014-12-23 |
2016-06-30 |
Variant Pharmaceuticals, Inc. |
Oral compositions for insoluble compounds
|
SI3265140T1
(sl)
*
|
2015-03-02 |
2021-11-30 |
Medlab Clinical U.S., Inc. |
Dostavni sistemi za dostavo skozi sluznico ali skozi kožo
|
US20170042806A1
(en)
|
2015-04-29 |
2017-02-16 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
EP3302429A1
(de)
|
2015-05-28 |
2018-04-11 |
Dr. Reddy's Laboratories Ltd. |
Orale zusammensetzung von celecoxib zur schmerzbehandlung
|
US20160346221A1
(en)
|
2015-06-01 |
2016-12-01 |
Autotelic Llc |
Phospholipid-coated therapeutic agent nanoparticles and related methods
|
US20170035781A1
(en)
|
2015-06-22 |
2017-02-09 |
Lipocine Inc. |
17-hydroxyprogesterone ester-containing oral compositions and related methods
|
ES2895910T3
(es)
|
2015-06-30 |
2022-02-23 |
Sequessome Tech Holdings Limited |
Composiciones multifásicas
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
US9585867B2
(en)
|
2015-08-06 |
2017-03-07 |
Charles Everett Ankner |
Cannabinod formulation for the sedation of a human or animal
|
WO2017040607A1
(en)
|
2015-08-31 |
2017-03-09 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for self-regulated release of active pharmaceutical ingredient
|
GB201518172D0
(en)
*
|
2015-10-14 |
2015-11-25 |
Cantab Biopharmaceuticals Patents Ltd |
Colloidal particles for use in medicine
|
TWI734715B
(zh)
|
2015-11-19 |
2021-08-01 |
美商卡默森屈有限公司 |
趨化因子受體調節劑
|
KR101710441B1
(ko)
*
|
2015-12-28 |
2017-02-28 |
신풍제약주식회사 |
안정성 및 용출성이 향상된 정제
|
KR20180101565A
(ko)
|
2016-01-20 |
2018-09-12 |
케모센트릭스, 인크. |
2-옥신돌 화합물
|
JP6998881B2
(ja)
|
2016-02-26 |
2022-02-10 |
デビオファーム・インターナショナル・エス・アー |
糖尿病性足感染症の処置のための医薬
|
US10064855B2
(en)
*
|
2016-03-08 |
2018-09-04 |
Los Gatos Pharmaceuticals, Inc. |
Composite nanoparticles and uses thereof
|
WO2017173044A1
(en)
*
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Steroid hormone compositions in medium chain oils
|
RU2018133932A
(ru)
|
2016-04-01 |
2020-05-12 |
Терапьютиксмд, Инк. |
Фармацевтическая композиция стероидного гормона
|
WO2017168174A1
(en)
|
2016-04-02 |
2017-10-05 |
N4 Pharma Uk Limited |
New pharmaceutical forms of sildenafil
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
WO2017222575A1
(en)
|
2016-06-23 |
2017-12-28 |
Collegium Pharmaceutical, Inc. |
Process of making more stable abuse-deterrent oral formulations
|
WO2018002673A1
(en)
|
2016-07-01 |
2018-01-04 |
N4 Pharma Uk Limited |
Novel formulations of angiotensin ii receptor antagonists
|
CN109922801B
(zh)
|
2016-09-09 |
2023-07-18 |
库蒂斯制药公司 |
甲硝唑和巴氯芬的混悬剂和稀释剂
|
CN110049754B
(zh)
*
|
2016-09-23 |
2022-12-06 |
Cj第一制糖株式会社 |
用于化妆品的脂肪酸乙酯
|
CN110022857A
(zh)
|
2016-11-18 |
2019-07-16 |
艾库里斯抗感染治疗有限公司 |
基于改性环糊精和酸化剂的脒取代β-内酰胺化合物的新制剂、其制备及作为抗微生物药物组合物的用途
|
BR112019010375A2
(pt)
|
2016-11-23 |
2019-08-27 |
Chemocentryx Inc |
método de tratamento de glomeruloesclerose segmental focal
|
WO2018098501A1
(en)
|
2016-11-28 |
2018-05-31 |
Lipocine Inc. |
Oral testosterone undecanoate therapy
|
BR112019011334A2
(pt)
|
2016-12-01 |
2019-10-15 |
Minoryx Therapeutics S L |
uso de 5-[[4-[2-[5-(1-hidroxietil)piridin-2-il]etoxi]fenil]metil]-1,3-tiazolidina-2,4-diona e seus sais
|
US20180207264A1
(en)
*
|
2017-01-23 |
2018-07-26 |
Government Of The United States As Represented By The Secretary Of The Air Force |
Porcine immune modulation model
|
IL273188B2
(en)
|
2017-09-25 |
2023-03-01 |
Chemocentryx Inc |
Treatment with a combination of chemokine receptor 2 (ccr2) inhibitors and a pd-1/pd-l1 inhibitor
|
WO2019075086A1
(en)
|
2017-10-11 |
2019-04-18 |
Chemocentryx, Inc. |
TREATMENT OF FOCAL SEGMENTAL GLOBEROSCLEROSIS WITH CCR2 ANTAGONISTS
|
GB2572126B
(en)
*
|
2018-01-03 |
2021-01-13 |
Gw Res Ltd |
Pharmaceutical
|
GB2572125B
(en)
*
|
2018-01-03 |
2021-01-13 |
Gw Res Ltd |
Pharmaceutical
|
GB2569961B
(en)
|
2018-01-03 |
2021-12-22 |
Gw Res Ltd |
Pharmaceutical
|
US10716774B1
(en)
|
2018-01-05 |
2020-07-21 |
Yale Pharmaceuticals LLC |
Pharmaceutical compositions containing isotretinoin with improved dissolution profile and enhanced stability
|
US10898434B2
(en)
*
|
2018-05-14 |
2021-01-26 |
Texas Christian University |
Single-walled carbon nanotube-assisted antibiotic delivery and imaging techniques
|
EP3793535A1
(de)
|
2018-05-16 |
2021-03-24 |
Bayer Healthcare LLC |
Formulierung mit hochkonzentrierter suspension für weichgelkapselmedikamente für erkältung und grippe
|
JP2022541398A
(ja)
|
2019-07-08 |
2022-09-26 |
リゾルート,インコーポレイティド |
血漿カリクレイン阻害薬の調製プロセス
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
HRP20231000T1
(hr)
|
2020-02-25 |
2023-12-08 |
Labomed Pharmaceutical Company S.A. |
Oralne otopine koje sadrže fludrokortizon acetat
|
US20210330698A1
(en)
*
|
2020-04-23 |
2021-10-28 |
Johnson & Johnson Consumer Inc. |
Methods and compositions for inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers
|
US20230225968A1
(en)
*
|
2020-06-20 |
2023-07-20 |
CHAVAN, Neha |
Process for producing visibly clear aqueous consumable products
|
EP4181912A1
(de)
|
2020-07-15 |
2023-05-24 |
Schabar Research Associates LLC |
Orale einzeldosiszusammensetzungen aus ibuprofen und famotidin zur behandlung von akutem schmerz und zur verminderung der schwere und/oder des risikos von sodbrennen
|
US11324727B2
(en)
|
2020-07-15 |
2022-05-10 |
Schabar Research Associates, Llc |
Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn
|
CA3091554A1
(en)
*
|
2020-08-28 |
2022-02-28 |
Triple Hair Inc. |
Formulations for reducing hair loss and/or increasing hair regrowth
|
US11452690B1
(en)
|
2021-01-27 |
2022-09-27 |
ECI Pharmaceuticals, LLC |
Oral liquid compositions comprising amlodipine besylate and methods of using the same
|
US11872320B2
(en)
|
2021-02-25 |
2024-01-16 |
Hisamitsu Pharmaceutical Co., Inc. |
Method for treating osteoarthritis
|
US11337987B1
(en)
|
2021-05-07 |
2022-05-24 |
Lipocine Inc. |
Compositions and methods for treating central nervous system disorders
|
US20230083749A1
(en)
*
|
2021-08-24 |
2023-03-16 |
Epalex Corporation |
Propofol compositions and methods of use
|
WO2024033521A1
(en)
|
2022-08-12 |
2024-02-15 |
GW Research Limited |
Oral solid dosage forms comprising cannabinoids
|